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Abstract
A synthesis of α-bromodiazoacetamides derived from cyclic, symmetric
amines is presented. The brominated α-diazoacetamides constitute a new
entry to the range of known α-diazoacetamides. Their thermolysis, at ambient
temperature, produce α-bromocarbene amides which undergo intramolecular
C−H insertion to form α-bromo bicyclic β-lactams.
The synthesis of the α-bromodiazoacetamides has been optimized with respect
to base and halogen source, and the scope of the intramolecular C−H insertion
reaction investigated by varying the ring size and substitution pattern of the
cyclic amine precursors.
xiii
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Part I.
Introduction

1. Diazo compounds as precursors for
carbenes/carbenoids
The first preparation and isolation of ethyl diazoacetate by Theodor Curtius
(1857–1928) a little over 125 years ago, marked the beginning of the era of
diazo compounds as reagents in synthetic organic chemistry.1a, 2 It would,
however, take another 50 years to merely determine that the structure of the
N2−CR2 moiety was indeed linear.1b A more thorough study of the electron
density distribution behind this geometry and the non-integral C−N and N−N
bonds was first made possible by modern spectroscopic methods and quantum-
mechanical theory.
Figure 1.1.: Electron distribution of α-diazocarbonyl compounds
The resonance hybrid of the diazo group is best described by the structures A
and B in figure 1.1, in which the largest contribution is made by B. In a similar
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manner, the diazocarbonyl compounds have three major resonance forms C, D
and E, here represented by their (Z)-rotamer. The contribution of structure E
is major for α-diazocarbonyl compounds1b (R1 = H) and is larger for amides
(R2 = NR2) than for esters (R2 = OR).
1c
Contrary to this, the most common way of depicting diazo compounds
in the literature is by means of structures of the type A or C, and most
often for α-diazocarbonyl compounds, they are drawn as the (E)-rotamer.
For α-diazoacetic esters in CDCl3-solution, the (Z)/(E)-ratio at 223 K was
found to be ~1.2:1.1d Moreover, the α-diazoacetamides characterized by X-ray
crystallography in this work, crystallized as their (Z)-rotamers. As such, the
α-diazoacetamides will be represented by their (Z)-rotamer and, for the sake of
congruence with the literature, the resonance forms A/C will be used throughout
this text.
Diazo compounds have gained popularity as nitrogenous precursors of
carbenes/carbenoids in synthetic organic chemistry. The potent reactivity of
carbenic species provides access to a host of transformations from diazo
precursors which are often relatively stable and easy to handle. Historically,
a common use of diazo compounds is in the formation of methyl esters from
acids with diazomethane. Apart from the advantage of the reaction being highly
selective, the lability of diazomethane and the occurrence of explosions1e have
possibly swayed workers from considering the use of any diazo compound
when designing their synthetic schemes. This lability, the propensity towards
dediazotization, is however influenced by the substituents on the carbon
bearing the diazo group to such an extent that the commercially available ethyl
diazo acetate, has been deemed safe by rigorous testing1f,1g and is frequently
employed by todays workers. As well as imparting stability against nitrogen
extrusion, the carbonyl group broadens the range of transformations relevant to
α-diazocarbonyl compounds as compared to diazomethane.
More generally, the reactions in which diazo compounds take part can be
categorized on the basis of whether or not the reaction pathway involves
the extrusion of dinitrogen and subsequent formation of a carbene/carbenoid.
For α-diazocarbonyl compounds, reactions of the type where dinitrogen is
lost include: β-hydride elimination, ylide formation and subsequent pathways,
4
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aromatic C−H insertion, aromatic cycloaddition (Büchner reaction), cycloprope-
nation, cyclopropanation, C−H and Y−H insertion (Y = O, N, S, Si) and
Wolff-rearrangement and subsequent pathways.3 On the other hand, among
the reactions of the type that does not involve the loss of dinitrogen, the most
important are 1,3-dipolar cycloadditions (diazo compounds are among the major
classes of known 1,3-dipoles) and electrophilic substitution reactions (vide infra).
Although most of the above mentioned transformations are relevant to
α-diazoacetamides as a substance class, this work is primarily concerned with
the intramolecular C−H insertion reactions of the α-bromodiazoacetamides
prepared from the corresponding α-diazoacetamides. The investigated method
of preparation of the α-halodiazoacetamides is an example of electrophilic
diazoalkane substitution,4 which is the topic of the next section.
1.1. Electrophilic diazoalkane substitution
The N2−CHR group take part in reactions with a wide range of electrophiles
in which the diazo function remains intact.4 Among the transformations are
substitutions of the diazomethyl hydrogen atom for electrophiles based on
silicon,5 phosphorous,6 boron,7 nitrogen (NO+2 ),
8 sulfur9 or halogens,10 as well
as carbon in aldol reactions with aldehydes,11 ketones12 and imines.13
An organic or organometallic base is usually required to generate an acid-base
complex or metallated derivative suitable for a given reaction. In aldol reactions
the use of catalytic or substoichiometric amounts of base (catalyst) is commonly
achieved, in some cases with recycling of the catalyst.13e
Bases of several strengths have been applied successfully, among them
members of the amine, amidine and guanidine families, as well as alkyl lithium,
5
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lithium amide and hydroxide bases e.g. diisopropylethyl amine (DIPEA),5f 1,8-
diazabicyclo-[5.4.0]-undec-7-ene (DBU),11d,13a tetramethyl guanidine (TMG),11e
lithium diisopropyl amide (LDA),12c n-butyl lithium (n-BuLi)5a,12a and rubidium
hydroxide (RbOH).11c
α-Diazoacetamides are, under similar conditions, reported to undergo elec-
trophilic substitutions with silicon5c and carbon in aldol reactions with aldehydes11a
and imines,13b,13c in reminiscence to the reactions reported for diazoacetates,
attesting to the similar electronic properties if the two in this reaction.
1.2. Halogenation of diazo compounds
Historically, the direct substitution of the diazomethyl hydrogen atom for
a halogen atom is only scarcely reported. The low temperature (−100 °C)
chlorination and bromination of diazomethane10a,10b and diazopropane10e
were accomplished with the corresponding t-butyl halites. The resulting
α-halodiazoalkanes were sensitive compounds, decomposing photolytically in
visible light above −65 °C and thermolytically above −40 °C.
The first syntheses of α-halodiazoacetic esters were reported by Gerhart and
Schöllkopf et al. in the late 1960s, who reacted the mercury derivative of ethyl
diazoacetate (EDA) with sources of electrophilic halogen (SO2Cl2, Br2 or I2).
This route allowed the workers to study the properties of the α-halo ethyl
diazoacetates and the reactivity of their photolytically derived carbenes.10c,10d,10f
Some ten years later Regitz et al. reported the syntheses of α-halodiazomethyl
phosphonic acid dimethyl ester and an α-halodiazomethyl diphenyl phospho-
xide, employing a similar strategy, starting from the silver derivatives of the
respective diazoaceto compounds.10g
More recently, a direct halogenation of ethyl diazoacetate at 0 °C was published
by Bonge et al.,10h which employs the amidine base 1,8-diazabicyclo-[5.4.0]-
undec-7-ene (DBU) and N-bromosuccinimide (NBS) as the halogen source. The
reaction proceeds to completion within minutes of the addition of the halogen
source to a solution of EDA and DBU in dichloromethane. The work-up yielded
the α-halo EDA in dichloromethane solution, which could be used directly in
6
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further reactions or the solvent could be changed to a higher boiling solvent
appropriate for the chemistry to follow. In the publication, toluene was added
and the dichloromethane evaporated at 0 °C using a rotary evaporator, before
submitting the α-halo EDA to dirhodium(II) catalyzed cyclopropanation with
styrene. The halogenation of higher esters using this method has not been
reported, but is currently being studied in our group.
1.3. Halogenation of α-diazoacetamides
There are to date no reports in the literature15 of α-halodiazoacetamides
as a substance class, suggesting that the electrophilic halogenation of a
α-diazoacetamide has not been investigated. Thus, to create an extension of
the current methodology to encompass the halogenation of α-diazoacetamides,
it seemed prudent to investigate the effect of alternative bases and sources
of halogen, alongside the reported combination, on the formation of the
α-halodiazoacetamides.
1.3.1. Bases
Base pKa Solvent
DABCO 8.5 DMSO14a
TMG 15.5 THF14d
DBU 16.9 THF14d
TBD 21.0 THF14d
Table 1.1.: Alternative bases
Looking at the bases employed in aldol re-
actions with α-diazocarbonyl compounds, the
guanidine base 1,1,3,3-tetramethylguanidine
(TMG)11e is a base of similar structure and
base strength. What also makes TMG an
interesting alternative, is the postulated inter-
mediacy, in bromolactonization reactions, of
an N-bromo-TMG cation as the active catalyst.16c This notion was substantiated
some time later by the isolation and crystallographic characterization of an N-
bromo amidine which proved to be an active catalyst in the same reaction.17a
In this vein, the diamine base 1,4-diazabicyclooctane (DABCO) should also be
of interest as it is reported to form a stable adduct with N-bromosuccinimide16b
which in turn can used for mild oxidations17b (halogenation probably involved).
Another highly basic member of the guanidine family, which is also bicyclic,
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is 1,5,7-triazabicyclo[4.4.0]dec-1-ene (TBD). The bases are listed in order of
increasing strength in table 1.1 on the previous page.
1.3.2. Halogenating agents
The halogenating agents that have been employed in the halogenation of diazo
compounds are: molecular halogen,10c,10d bromocyan,10g t-butyl halites10b,10a,10e
and N-halo succinimides.10h The N-halo succinimides are widely employed in
organic synthesis as sources of electrophilic halogen as they present advantages
like straightforward syntheses, ease of handling, storage stability and enhanced
chemoselectivity over that of molecular halogen in certain transformations.18e
Many of these favourable characteristics can be extended to other N-halo imides,
such as N-bromophthalimide (NBP), as well as to other sources of electrophilic
halogen such as N-halo amides, N-halo sulfonamides, N-halo saccharins and
N-halo disulfonimides.18f,18d None of the latter have been investigated in the
halogenation of diazo compounds.15
The activity of N-halo reagents in heterolytic (polar) reactions can reasonably
be related to the stability of the resulting amide, imide or sulfonimide anion,
resulting from the heterolytic cleavage of the N−halogen bond.18a,18c In
bromolactonization reactions, such a trend was observed, although it was not
reflected in the yield of all the entries.18b The authors proposed that the acid
dissociation constant of the corresponding amide, imide or sulfonimide can
indicate the polarity of the N−halogen bond and thus the propensity of a given
reagent towards furnishing a halonium ion in a heterolytic reaction pathway. The
acidities of relevant scaffolds from which to make N-halo reagents, have been
listed in table 1.2.
Amide pKa (DMSO)
2-pyrrolidone 24.214b
Succinimide 14.614b
Phthalimide 13.414c
Saccharin 4.014b
Table 1.2.: Amide acidities
The ease with which the α-halodiazoacetates
extrude nitrogen, reflected in their ther-
mal lability (they decompose over hours at
0 °C),10c,10h is also an indicator of their lability
towards acids.19 The protonation of the basic,
negatively charged carbon bearing the diazo
group, is an expedient way to effect nitrogen
8
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extrusion. This is indeed the intended pathway in acid-catalyzed cyclizations
of diazoketones.27d Not knowing the stability of α-halodiazoacetamides as a
chemical species, raises the question of whether weak acids like the amides,
imides and sulfonimides corresponding to the N-halo reagents, would have a
detrimental effect on the produced α-halodiazoacetamides.
The results of the investigation of different bases and N-halo reagents in
the halogenation of α-diazoacetamides, can be found in chapter 4 on page 41.
The next chapter introduces carbenes/carbenoids, and discusses the position
of the carbenic species derived from halogenated diazo compounds, before
introducing transition metal catalysis and selectivity considerations in C-H
insertion reactions.
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2. The carbene/carbenoid route to
β-lactams
2.1. Carbene types and philicities
A carbene is a divalent carbon atom with 6 electrons in its valence shell. For
most carbenes this means an sp2-type hybridization, where two of the sp2 hybrids
are occupied by the substituents. The last electron pair can be distributed in the
remaining non-bonding sp2 hybrid and the py orbital. Carbenes thus possess the
possibility of ground state spin multiplicity. There are four possible distributions
of the two electrons with two possible spins in the two non-bonding orbitals. Of
these four, the one which has two spin paired electrons in the sp2 orbital, the
orbital in plane with the substituents, and an empty py orbital, is the unexcited
singlet carbene, which is most relevant to this work.20i The sp2 and py orbitals
will be referred to as the σ and ppi orbitals in the rest of this text.
It has been shown that the interactions of the substituents with the carbene
carbon σ and pi orbitals, dictate which electronic state will be its ground state.
In evaluating the carbenic species involved in this work, α-halocarbenes- and
carbenoids, the conclusion is reached that they should be singlet carbenes. This
is because the singlet state is favoured by a large energy difference between the
ppi and the σ orbital. The pi-donating interaction of the lone electron pairs on the
halogen atom to the vacant ppi orbital is destabilizing, which increases the energy
of the ppi orbital and thus the ppi – σ gap.
Substituents of high electronegativity are found to stabilize the electron pair
in the σ orbital through σ-electron withdrawal, which increases the orbitals
s-character, thus lowering its energy. More importantly, the carbonyl (amide)
group can stabilize the lone pair in the carbene σ orbital by an overlap with
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the vacant p orbital of the carbonyl carbon which is in plane with the carbene
σ orbital.20i Similarly, the conclusion was reached by others, about the related
α-halocarboethoxycarbenes derived from α-halodiazoacetic esters, that they are
also singlet carbenes.10f The stabilizing effect of the vacant p orbital of the
carbonyl carbon on the electron pair in the carbene σ orbital, should be stronger in
esters than in amides, owing to the presence of the lone electron pair on the amide
nitrogen. This would indicate that the α-halocarbene esters are more stabilized
than their corresponding α-halocarbene amides.
The electronic distribution of singlet carbenes make them inherent ambiphiles;
one orbital has a nucleophilic non-bonding electron pair and the other is vacant
and thus electrophile. One of the first carbenes known - methylene - is intensely
electrophile (vide infra) and it was long believed that this was the only reactivity
mode of the carbenes.20j The much wider range of carbene philicities is the topic
of the next section.
2.1.1. Reactivity and selectivity of carbenes
Some 50 years ago the simplest of the carbenes, methylene, was described by
William von Eggers Doering as "... the most indiscriminate reagent known in
organic chemistry." This description owed to the near statistical product ratio
obtained upon photolysis of diazomethane in 2,3-dimethylbutane, with respect
to 1° vs. 2° vs. 3° C−H insertion. A similar absence of chemoselectivity was
observed upon photolysis of diazomethane in cyclohexene, with respect to
cyclopropanation vs. 2° homoallylic vs. 2° allylic vs. vinylic C−H insertion.20b The
latter result was much unlike the selectivity with which :CCl2 and :CBr2 would
cyclopropanate the double bond in cyclohexene,20a let alone the observation that
the rates of reaction of :CBr2 increased with increasing olefin substitution.
20c,20d
In other words, the substitution of the diazomethyl hydrogens for halogens,
had a tremendous impact on the selectivity of the resulting carbene towards
the available “nucleophiles“ (olefins and C−H bonds). Over the next five
decades several workers, among them Robert A. Moss,21 studied a number
of heterocarbenes (carbenes with substituents other than H) and their relative
rates of cyclopropanation of a standard set of olefins in order to quantitate
the selectivity with which they reacted. Many of the works in question have
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been reviewed by Moss.20j Today, these results constitute a cornerstone in a
more general understanding of the diverse reactivity profile of carbenes - from
electrophilic through ambiphilic to nucleophilic.
Moss’ scale of carbene philicity was based on the cyclopropanation of
increasingly electron-rich olefins with electrophilic carbenes. The scale was later
extended to include electron-poor olefins, as it became clear that carbenes like
:C(OMe)2 behave as nucleophiles, reacting at increasing rates with increasingly
electron-deficient olefins. Many nucleophilic carbenes are known today, and in
analogy to the cyclopropanation of electron-deficient olefins, selecting the correct
substrate has made C−H insertion of nucleophilic carbenes possible.20h The
further discoveries of Arduengo20g and Bertrand20i of stable, isolable carbenes
add to the impressive width of carbene reactivity. In summary, the diversity of
transformations in which the divalent 6-electron carbon can take part, reinforces
its fundamental importance in chemistry alongside carbanions and carbocations.
Carbenes can now be characterized in terms of either electrophilic selectivity or
nucleophilic selectivity of which the former, for now, is the most frequently used.
The above discussion delineates the context in which the α-halocarbonylcarbenes
reside. As for the electrophilic selectivity of α-bromocarboethoxycarbene com-
pared to the halocarbenes and bromophenylcarbene, it has been shown that it
is among the least selective, which means it is among the most reactive. It is,
however, more selective and less reactive than carboethoxycarbene.20f Given that
a C−H bond is a much poorer ”nucleophile“ than a double bond, the need for a
correspondingly electrophilic carbene can possibly make use of this trait, given
that other pathways are not available to the less discriminate carbene.
The carbenes that are complexed with other atoms during reaction, have
gained the name carbenoids, owing to the influence of the complexation on their
”natural“ reactivity. The discussion around what is a real or ”free” carbene is
outside the scope of this text, but has been probed with interesting experimental
techniques elsewhere.20e,20k In carbenoids, the complexed atom is most often
a transition metal. The transition metal carbene complexes and especially the
dirhodium(II) complexes, are the topics of the next section.
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2.2. Metal carbene complexes and transition metal
catalysis of diazo compounds
The extrusion of nitrogen from a diazo compound, to generate a carbenic
intermediate, can be effected thermally, photolytically, by protonation by a
Brønsted acid or by coordination to a Lewis acid.19 The Lewis acid is often a
transition metal, e.g. the powdered metal, a salt such as CuSO4, but more often,
and of greater synthetic potential, a ligated transition metal catalyst.
The metal carbene complexes, are referred to as metal carbenoids, or simply
carbenoids, to indicate their similar yet distinct reactivity as compared to
that of the ”free” carbenes, generated by photolysis or thermolysis. Through
experimentation and computational studies, this reactivity difference has been
observed and rationalized in terms of properties of the carbene and its precursor,
and importantly, in terms of the properties of the metal and its ligands.25i,23a,23c
The potential for strategically modulating the reactivity of a metal carbene
complex, by the variation of the ligands bound to the metal, has inspired the
input of considerable efforts to investigate and rationally design competent
catalysts. The result of these efforts is a broadening of the synthetic utility of a
given carbene precursor, e.g. a diazo compound, through the possibility to almost
exclusively induce a given reaction path based on the choice of catalyst.22c,23b
By today, the synthetic potential of carbene transfer reactions involving
transition metal catalysts, has been demonstrated in most facets of carbene
chemistry. Only in the area of C−H insertion reactions, impressive examples exist
in which excellent chemo-, regio- and enantioselectivity has been achieved.22b,22f
Members from nearly all the periodic groups of transition metals are featured
in catalysts for carbenoid transformations, and a number of metals and catalyst
morphologies have been employed in catalysts that are competent in carbene
transfer reactions.22a Among the catalysts that have had the greatest success to
date, are those derived from ligated Cu 2+- and Rh 4+2 -cores.
The morphologies of the copper(II) catalysts depend on the structure, bite and
number of ligands. Among the many notable copper(II) complexes are those
14
Dirhodium(II) catalysts - morphologies and syntheses
ligated by box-type ligands, which have found special utility in intermolecular
N-H insertion reactions, where they have yielded α-carbonyl amines with
excellent enantiomeric excesses.22e Still, the catalysts that have received the most
attention to this day with respect to carbenoid chemistry, are the dirhodium(II)
catalysts. This work will attempt to employ prototypical dirhodium(II) catalysts
in the intramolecular C−H insertion of α-halodiazoacetamides. Therefore, the
following sections will discuss the morphology and synthesis of dirhodium(II)
catalysts, before moving on to a discussion of selectivity in carbene/carbenoid
C−H insertion reactions, with relevance to the ones attempted in this work.
2.3. Dirhodium(II) catalysts - morphologies and
syntheses
A large diversity of dirhodium(II) complexes are reported in the literature,22d and
far from all have found use in catalysis involving diazo compounds. A collection
of three prototypical dirhodium(II) catalysts relevant to catalytic reactions with
diazo compounds, are shown in figure 2.1 on the following page. The homoleptic
complexes share the common structural feature of four chemically equal ligands
bridging the Rh-Rh bond, the bridging unit being typically a monoanionic three-
atom bidentate group. The Rh2(tfa)4 and the Rh2(cap)4 are both examples of this.
Complexes like Rh2(OAc)2(pc)2 found use as catalysts in carbenoid chemistry
years after the domains of the other families were established, although the
complex had been known for some time.
The paddlewheel-like dirhodium(II) complexes, are neutral, 14 electron
complexes with free coordination seats axially. These seats are made up of the 4d2z
orbitals on the outer face of each rhodium atom, in the axis of the Rh-Rh single
bond.24e The Lewis acidities of the axial seats are influenced by the electronic
properties of the bridging ligands as well as those of a ligand coordinated to
one of the axial seats. Bridging ligands that are electron withdrawing increase
the Lewis acidity, thus making Rh2(tfa)4 a stronger Lewis acid than Rh2(OAc)4,
which in turn is more acidic than Rh2(OAc)2(pc)2 (pc = orthometalated PPh3) and
Rh2(cap)4.
15
The carbene/carbenoid route to β-lactams
Figure 2.1.: Representatives from three dirhodium(II) catalyst families. Decreasing Lewis acidity
from left to right.
The axial seats coordinate most Lewis bases, even weak ones like H2O, which
will be coordinated if the complex is exposed to air over longer periods of
time. The more acidic Rh2(tfa)4 and Rh2(OAc)4 will even coordinate olefins
in solution, whereas the remaining two will not.23a The coordination of one
axial ligand, decreases the rate at which the second seat is occupied.25g,25m
The Rh−L bond (L = axial ligand) is fairly labile with weaker donors, which
are easily displaced. In example, axially coordinated acetonitrile molecules can
be displaced by dissolving the complex in a weakly coordinating solvent like
CH2Cl2. Stronger donors are conversely not easily displaced, and since the axial
seats are the site of reaction with the Lewis basic diazo carbon, strong Lewis bases
will poison the catalyst, as they competitively inhibit the coordination of the
diazo compound. Another distinct characteristic of axial ligation in dirhodium(II)
complexes, is the colour the presence or absence of different axial ligands will
impart on the complex - from brown through red and green to blue.
Historically the dirhodium(II) complexes have been synthesized either by
the concomitant construction of the dirhodium core with ligands, or by the
substitution of the ligands on an existing dirhodium(II) core. The reaction of
RhCl3 · 2 H2O with NaOAc in CH3CO2H/EtOH yields Rh2(OAc)425a – which
together with Rh2(tfa)4 are the most common substrates for ligand exchange
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reactions. These exchange reactions are normally driven to completion utilizing
azeotropic distillation from chlorobenzene or toluene in which the azeotrope
with CH3CO2H is distilled out of the flask or captured by a base in a Soxhlet-
extractor thimble.25f,25n
As alternatives to the removal the released acetic acid, the reaction of
Rh2(OAc)4 with an alkali metal salt of the ligand, as in the synthesis of Rh2(py)4
(py = pyrazole),25b or the reaction of Na4Rh2(CO3)4 and the ligand as a free
carboxylic acid, will yield a tetraligated Rh 4+2 -core. The latter method was
employed by McKervey et al. to synthesize a series of dirhodium(II) carboxylates,
both monodentate and bidentate.25e
Another, perhaps surprising method, considering that in the starting material
the Rh 4+2 -core is ligated by acetate groups, is to run the ligand exchange
reaction in acetic acid. This technique was reported in the ligand exchange with
arylphosphines25c,25d and 1,8-naphthyridine.25k
In the synthesis of the complex Rh2(OAc)2(pc)2, by orthometalation of PPh3,
only two acetates are exchanged and the phosphine ligands become positioned
in a head-to-tail arrangement, that is, the phosphorous atoms are bound to each
their rhodium atom. The resulting cis-configuration will, although the ligands
are achiral, yield an axially chiral complex. The syntheses of orthometalated
arylphosphine complexes thus afford racemic mixtures of enantiomers M and
P (cf. figure 2.1 on the preceding page). If desirable, the remaining acetate
ligands can be exchanged for monochiral carboxylate ligands (e.g. proline
derivatives) yielding diastereomers, which can then be separated on common
chromatographic media. To obtain the pure enantiomers M and P, the prolinate
groups are then exchanged for acetate groups.25h If the orthometalation is carried
out with chiral phosphines, diastereomers result as well.25j
In this work, the syntheses of Rh2(OAc)2(pc)2 · 2 MeCN and Rh2(cap)4 · 2 MeCN
have been carried out so that these catalysts can be employed, in addition to the
commercially available Rh2(tfa)4, in the intramolecular C−H insertion reactions
of α-halodiazoacetamides. The catalysts have been purified by a novel method
which is described in detail in chapter 13 on page 113 in the experimental section.
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In the next sections, the focus is turned to the mechanism and later the
selectivity of C−H insertion reactions with carbenes and carbenoids.
2.4. The C−H insertion reaction - mechanism and
selectivity
The experimental results that form the basis for Moss’ selectivity concept for
the heterocarbenes, have a parallel in the literature on the metal carbenoids.
The dirhodium(II) catalysts possess an important feature; their ability to donate
electron density to suitable orbitals on the carbon atom with which they are
complexed. The result of this donation is a modulation of the selectivity inherent
to a given carbene, in contrast to its “free” carbene behaviour. In order to discuss
this concept it is prudent to look at the general electronic trends among the
families of dirhodium(II) complexes. The electron withdrawal of the ligands,
that is, the electronegativity of the elements in the bridging group and the rest
of the ligand, and more rarely the electron withdrawal of a group in resonance
with the Rh 4+2 -core, decrease the electron density available for donation. The
dirhodium(II) perfluorocarboxylates are thus the most electron deficient, and
those least capable of donation of electron density. Moving in the opposite
direction, we find the carboxylates e.g. those derived from proline,24d the
orthometalated arylphosphines and finally the carboxamidates.
There are several occasions in which the varying electron-richness of a
dirhodium(II) complex needs to be considered in the context of catalysis: The
diazo compounds are Lewis bases and will more easily form Lewis acid-base
complexes with the more acidic catalysts. The formation of these complexes is the
first step in the catalytic cycle, as it has recently been described by computational
methods (DFT) for aliphatic C−H insertion reactions of methyl diazoacetate.24e
The second step involves nitrogen extrusion and formation of the metal
carbene complex. During this step, electron density moves from the 4dxz orbitals
on Rh atom to which the diazo carbon is coordinated, into the σ∗ orbital of the
C−N bond in the complexed diazo group, helping to drive off dinitrogen.
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Upon formation of the the metal carbene complex, the donation from the Rh-
atom can be found in the ppi orbital on the carbene carbon. This added electron
density will exercise a modulation of the electrophilic selectivity of the metal
carbene complex (vide infra). Interestingly, at this point, the carbonyl group pi
bond of methyl diazoacetate is found to be in conjugation with the Rh−C σ bond,
in analogy to the free carbene, where it is in conjugation with the electron pair of
the non-bonding σ orbital (cf. section 2.1 on page 11).
In the step in which the C−H insertion takes place, a transfer of a hydride from
the substrate to the carbene ppi orbital precedes the C−C bond formation.24e It has
been observed, that in substrates with activated C−H bonds, the hydride transfer
tends to be further advanced in relation to the C−C bond formation.26c
An additional consequence of the differential ability of the dirhodium(II)
catalyst to donate electron density, from here referred to as back-donation, should
be considered. The trends of Lewis acidity and back-donative ability are roughly
opposite. This could imply that there is a balance between the frequency of
Lewis acid-base complex formation (given that it is reversible) and the frequency
with which such a complex proceeds to the rate determining step, which is the
nitrogen extrusion aided by back-donation from the catalyst. Certainly, the fact
that back-donation is involved, does not necessarily mean that nitrogen extrusion
depends on it. Still, it may well be that the less Lewis acidic catalysts maintain
their apparent reactivity with the help of back-donation, to a larger extent than
those more Lewis acidic.
The influence of the catalyst ligands on the selectivity in reactions where
multiple pathways are possible, have been compiled from the yields of the
different products. The amount of back-donation exercised by a given catalyst,
has been shown to be important for the electrophilic selectivity with which
the dirhodium(II) carbenoid reacts with both olefins and C−H bonds. The
consequence of increased electron population in the carbene ppi, should as it is
for the carbenes (cf. section 2.1 on page 11), be an increase in energy of the ppi
orbital and subsequently a larger σ - ppi energy gap, which in turn leads to a
stabilization of the metal carbene complex.23c This is linked to an increasingly late
transition state in a given reaction of the metal carbene complex,23a,23b,22f which
is expressed in the chemoselectivity and regioselectivity trends seen in figure 2.2
on the next page.
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Figure 2.2.: Empirical selectivities in C-H insertion by dirhodium(II) carbenoids
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As can be seen in figure 2.2, the selectivity for the better nucleophile and for
the reaction with the later transition state increases with the increasing back-
donating capability of the catalyst. The order of preferential reactivity in the
different systems are:
A 24b Olefin cyclopropanation > 3° C−H insertion
B 23a 3° C−H insertion > 1° C−H insertion
C 24b 5-membered ring formation > 4-membered ring formation
In relation to entry C, it is clear that the differentiation between the pathways to
the 4- or 5-membered rings, given that both the α-and β-positions are methylenes,
is governed by the stability of the carbenoid. The formation of the 4-membered
ring thus proceeds through an earlier transition state. Still, selectivity is not very
high when both insertion points are relatively unhindered.
Additionally, not shown in the figure, is the phenomenon of α-activation
by heteroatoms24a,24d and the α-and sometimes β-deactivation24a by electron
withdrawing substituents. These trends are rationalized by the stabilizing or
destabilizing electronic effect of the heteroatom or the electron withdrawing
group, on the build-up of positive charge during the C−H insertion transition
state (involving hydride transfer). 24e The β-deactivation, however, does not
always appear to exercise regiocontrol.24c In relevance to this work, a concept
that apparently has not been investigated in the same way as shown in figure 2.2,
is how back-donation and subsequent stabilization of the metal carbene complex,
affects the outcome of a reaction where the number of productive pathways is
restricted and in which the C−H insertion is conformationally difficult.
In this perspective, the carbene dimerization reaction should be mentioned.
Dimerization to yield the olefinic formal carbene dimer, is thought to occur either
by the combination of two carbenes, or by the electrophilic attack of a carbene
on the nucleophilic carbon of a neighbouring diazo compound, consequently
effecting nitrogen extrusion and dimer formation. Apparently not reported,15 is
whether increased back-donation increases the selectivity for the dimerization
processes relative to other productive pathways.
Being a common by-product in many reactions of carbenes/carbenoids, it
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appears there is a disregard for the dimeric species, and it is considered by many
workers in diazo chemistry, as a product without further synthetic value. In
contrast, and possibly following a pathway similar to that of dimerization, is the
formation of alleged syndiotactic (e.g. highly ordered, almost crystalline) high
molecular weight polymers from EDA using a Rh(I) catalyst.24f This example
indicates that carbene self-coupling processes can indeed be of synthetic value,
as well as it emphasizes that carbene self-coupling processes not always lead to
the olefinic dimer. The possibility that a by-product observed in the reactions
performed in this work could stem from a self-coupling process is discussed in
section 4.3 on page 46.
The next section focuses on the formation of bicyclic β-lactams and strategies
involving carbenes that have had success in their preparation
2.4.1. β-lactam formation
The ability of carbenes and carbenoids derived from α-diazoacetamides to insert
into C−H bonds α and β to the amide nitrogen, has been exploited in the
preparation of both β-and γ-lactams. Focusing on the formation of β-lactams,
and especially on the efforts to establish bicyclic systems, most of the reactions
reported in the literature15 were carried out to prepare nuclear analogues of
penicillin and cephalosporin antibiotics. More specifically, p-tosylhydrazones
were treated with a strong base, or the corresponding α-diazoamides subjected
to photolysis or thermolysis to yield carbenoids/carbenes which in all cases
underwent C−H insertion to afford β-lactams in moderate to excellent yields.27
About two decades after the earliest publications, reports of dirhodium(II)-
catalyzed reactions appeared, also providing chemoselectivity and high yields.
Most of the α-diazoamides (or hydrazones) in question, had substituents other
than H on the carbon bearing the diazo group. Still, examples of successful
application of α-diazoacetamides have been reported using photolysis,27b,27c
thermolysis,27b and dirhodium(II) catalysis.27f,37h In the aforementioned publica-
tions, the second substituent on the diazo carbon is frequently a phenyl27a,27b,27h
or a carbonyl group,27c but examples of an arylsulfonyl group27e and dialkylphos-
phono groups27g can also be found. All of the above mentioned substituents
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are commonly employed in synthesis with α-diazoamides in non-cyclic systems.
In general, the C−H insertions with the disubstituted carbenic species have
been more successful than the monosubstituted, both in terms of yield and
diastereoselectivity.
Having the possibility to insert into C−H bonds on either face of the cyclic
amide residue, the most abundant diastereomer obtained in the bulk of these
reactions is the one in which the second carbene substituent and the ring residue
are in a trans-relationship, leaving them on opposite sides of the β-lactam plane.
As stated above, the bicyclic β-lactams are nuclear analogues of penicillin
and cephalosporin antibiotics. However, as one of the publications states, the
obtained bicyclic β-lactams showed no antibacterial activity.27c For the β-lactams
fused with 6-membered rings, this can be correlated with their lower reactivity
towards hydrolysis as compared to the β-lactams fused with 5-membered
rings.27b
The α-halo-β-lactams (halo = Cl, Br) derived from piperidine, cis/trans-7-halo-1-
azabicyclo[4.2.0]octan-8-one, as well as a few other α-halo-β-lactams more closely
resembling antibiotics, were prepared some 30 years ago and their synthesis was
indeed accomplished by a carbene/carbenoid route.28 This reaction was based
upon Seyferths discovery that halomethylphenylmercury compounds readily
fragment to phenylmercury halides and halocarbenes.29 Thus, the thermal
decomposition of N,N’-dihalophenylmercury amides yielded phenylmercury
halides and α-halocarbene amides which underwent intramolecular C−H
insertion to form the bicyclic β-lactams. The diastereomers of the α-halo-
β-lactams derived from piperidine were separated and characterized by NMR,
MS and elemental analysis. The stereochemical assignments were made by
NMR in correlation to previously published β-lactam structures,28 and are the
background for the assignments made in this work (cf. the experimental section)
In this work, the intramolecular C−H insertion reactions of α-halodiazoacetamides
will be investigated for a set of α-diazoacetamides derived from cyclic amines
(see figure 3.2 on page 28). If the reactions are successful, they will afford α-halo-
β-lactams. The presence of a halogen in the α-position of the β-lactam should
render it a good electrophile and possibly a viable cross-coupling partner. In
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such a reaction scheme, the relative hydrolytic stability of the β-lactams fused
with 6-membered rings, can prove itself a valuable trait. The latter statement
assumes that the presence of the halogen does not increase the propensity
towards hydrolysis. A brief discussion of possible coupling conditions can be
found in chapter 5 on page 53.
The syntheses and applications of the α-halodiazoacetamides are treated in
chapter 4 on page 41. The next chapter is concerned with the preparation of the
α-diazoacetamides to be halogenated.
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Part II.
Experimental Results and
Discussion

3. Synthesis of α-diazoacetamides
Figure 3.1.: Routes of synthesis of α-diazoacetamides labelled A-I.
Over the last decade, since the first syntheses of ethyl diazoacetate30a and
diazomethane,30b the number of synthetic methods that form a diazo group
within a molecule has grown continuously.30c The discoveries of a wide range
of precursor moieties suited for transformation into a diazo group, create ample
possibilities for the inclusion of diazo chemistry in a synthetic strategy. Such
structural flexibilities aside, only a few of the newer approaches can outperform
the two longest standing methods, alkaline cleavage of N-alkyl-N-nitrosoureas
and amine diazotization, with respect to two general drawbacks in the synthesis
of the diazo group: atom economy and cost. Moreover, not all of the known
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routes are applicable in the synthesis of α-diazoacetamides. The possible synthetic
approaches are depicted in figure 3.1 on the preceding page.
One goal of this work was the synthesis of α-diazoacetamides from readily
available cyclic, symmetric amines. As such a collection of amines was
purchased. Their names and indexes, which will be used throughout the rest
of this work, are shown in figure 3.2. The structures appearing in the coming
synthetic steps will gain their indexes from an alphabetical increment in the letter,
so that the synthetic products derived from e.g. piperidine are called 2b - 2e.
Figure 3.2.: Amines employed in the synthesis of α-diazoacetamides
3.1. The choice of synthetic strategy
In order to choose what synthetic strategy to employ, the routes marked A - I
in figure 3.1 on the preceding page have been evaluated with respect to atom
economy and cost, starting from an amine. In pathways where several reagents
are suggested, the relevant reagents are marked with the letter corresponding to
the route in question. A brief description of the synthetic routes corresponding to
the letters A - I is given in table 3.1 on the next page.
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Route Description
A The Toma procedure31a using N,N’-ditosylhydrazine and DBU
B This work, the Toma procedure31a using N,N’-ditosylhydrazine and TMG
C A hypothetical route, the Toma procedure31a using N,N’-dimesylhydrazine31b and TMG
D A Gabriel-synthesis followed by Curtius diazotization32a,32b
E A peptide coupling followed by Curtius diazotization32a,32c
F Diazoacetyl transfer as published by Ouihia33b
G The House/Blankley procedure. Acylation with glyoxylic acid chloride p-tosylhydrazone15,34a,34b
H Regitz diazo transfer35b using p-acetamido benzenesulfonyl azide (p-ABSA) and DBU35f
I Regitz diazo transfer35b as modified by Doyle using mesyl azide and triethylamine35a,35c,35d,35e
Table 3.1.: A short description of the possible synthetic routes to α-diazoacetamides
The concept of atom economy applied in this calculation is that of Barry
Trost36a and the following terminology36b is used: The Atom Economy of
the reaction sequence in question is the molecular weight of the introduced
diazoacetyl group (MW 69 g/mole) divided by the sum of the molecular weights
of the reagents used to introduce it. As an extension of this term, the Experimental
Atom Economy is similarly the molecular weight of the introduced group
divided by the molecular weights of the reagents, which this time, is multiplied
by their respective molar equivalents. Finally, the term Experimental Atom
Economy × Yield provides an overall impression of how many moles of reagents
are spent compared to how many moles of product that can be isolated. The
last of these terms, is the most informative and is thus the only one included
in table 3.2 on the following page.
The costs are calculated in accordance to the reagent equivalents and overall
yields given in the cited procedures (see table 3.1) for structures similar to the
ones in this work. Therefore, the cost calculation is not generally applicable
in principle, although in all the described procedures the amines function
as nucleophiles and there is little doubt that most cyclic amines are capable
reagents as such. All the necessary reagents are included in the calculation, also
those needed to prepare the key nitrogen containing reagents. Solvents are not
included. Reagent prices are representative of the least expensive option for each
item (often larger quantities) available to the Department of Chemistry at the
University of Oslo, through the Sigma-Aldrich web site, in June 2010. Hence,
they do not necessarily reflect industrial production prices, and must at best be
regarded as indicative.
As can be observed in table 3.2 on the following page, the overall efficiency in
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Table 3.2.: Cost in € and atom economy calculations per mole of diazoacetamide for
different synthetic strategies. Cost figures are rounded off to the nearest
tenth.
Synthetic
strategy
€/mole
producta Yieldb
Yield × Experimental
Atom Economy
A 920 73% 2.6%
B 530 60% 2.0%
C 280 60% 2.3%
D 120 53% 1.8%
E 120 36% 5.2%
F 500 98% 9.7%
G 470 75% 6.4%
H 400 88% 3.6%
I 90 48% 5.3%
a Calculated using currency conversion rates dated 14.07.2010
b Overall yield from the point of introduction of the amine
the preparation of diazoacetamides, starting from an amine, is quite low. Worthy
of note, is the fact that the largest differences between the atom economies of the
various routes, is no more than fivefold (cf. entry F vs. D), compared to the tenfold
difference in cost between the routes A and I. As well, the most atom efficient
route is among the top three in cost, while the least expensive route is the third
most atom efficient route (Route I). This owes much to the fact that the modified
Regitz35b diazo transfer route, using diketene and mesyl azide/Et3N comes at a
surprisingly low cost considering the extra step (cf. figure 3.1 on page 27). It is
also more efficient than the diazo transfer with p-ABSA and DBU, even though
the reported yield in the latter procedure is higher. It is also worth noting that the
preparation of succinimidyl diazoacetate (route F) and glyoxylic acid chloride p-
tosylhydrazone (route G), are one and two step processes respectively, which are
not necessarily convenient or easy to perform (vide infra). The route F is, however,
the most desirable strategy to employ if the amine is either costly or in shortage
as a function of synthetic steps needed to prepare it.
Included in the table 3.2 is the result of the same cost and atom economy
calculation with respect to this work (Route B). The numbers show that the
modifications made to the original procedure (Route A) had some positive
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impact on the cost, although the yields were slightly lower (vide infra). A further
hypothetical improvement to this strategy using N,N’-dimesylhydrazine instead
of N,N’-ditosylhydrazine, would if the yields were equal, improve the cost
efficiency even further (Route C).
3.2. Experimental results
Apart from atom economy and cost, a trait of useful synthetic transforma-
tions is scalability. Given that the investigation of the halogenation of the
α-diazoacetamides would require access to ample amounts of the diazo com-
pounds, it was desirable to prepare the α-diazoacetamides at a 10 - 50 millimole
scale.
Starting out, both routes G and F were explored due to their widespread use
in the literature. These routes intercept each other at the point of the glyoxylic
acid p-tosylhydrazone (which is easily prepared by the reaction of glyoxylic acid
and p-tosyl hydrazide).34b As has been reported by others,34b,33a the preparation
of the corresponding acid chloride (route G) was difficult, also in our hands, in
terms of its synthesis and purification.
Succinimidyl diazoacetate on the other hand (Route F), is reported to be
a shelf stable reagent which can be prepared by the dicyclohexyl carbodi-
imide (DCC)-mediated coupling of N-hydroxysuccinimide and glyoxylic acid
p-tosylhydrazone,33b a reaction which simultaneously dehydrogenates the hy-
drazone to form the diazo group. However, this procedure was not successful
owing to the difficult chromatographic separation of the dicyclohexylurea (DCU)
produced in the coupling and the succinimidyl diazoacetate. Succinimidyl dia-
zoacetate has been prepared by Doyle33c on a large scale (40 g) by the acylation
of N-hydroxysuccinimide with glyoxylic acid chloride p-tosylhydrazone. This
route was not pursued by us in consequence of our difficulties in preparing
the glyoxylic acid chloride p-tosylhydrazone. Interestingly, succinimidyl diazoac-
etate has recently been used in enantioselective cyclopropanations of olefins with
chiral cobalt(II)-porphyrin catalysts, establishing asymmetry before introducing
the amide function.37b
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Our next attempt focused on a publication by Toma et al.31a in which the diazo
group was introduced by a novel reaction between N,N’-ditosylhydrazine and
several α-bromo esters (Route A). The mechanism, although not fully elucidated,
appears to involve an SN2 reaction followed by steps reminiscent of those found
in the dehydrogenation of hydrazones. A short mechanistic proposal based
on what is described in the publication is shown in figure 3.3. In the step in
which the intermediate is a tautomer of a hydrazone, the hydrazone is shown
in parentheses.
Figure 3.3.: A tentative mechanism for the base-induced introduction of the diazo group with N,N’-
ditosylhydrazine
Although this approach had not been reported for the preparation of
α-diazoacetamides, it seemed likely that it would be compatible, given that the
α-bromo amides would react similarly to the α-bromo esters. Thus, the amines 1a-
8a were bromoacetylated in high yields with bromoacetyl bromide and tribasic
K3PO4, as shown in figure 3.4 on the facing page. The use of K3PO4 instead
of Na2CO3, as in the original publication, was founded on the results of an
optimization study of the acylation of amines with respect to different bases,
which concluded that K3PO4 was optimal for this type of reaction.
31c Indeed,
the reaction was clean, and no purification besides the work-up was needed to
provide compounds pure enough to be used directly in the subsequent step (cf.
the crude NMR spectra in the appendix).
Unfortunately, the analogue 7b became a brittle lacquer upon evaporation of
the solvent, which was completely insoluble in solvents suited for the next step.
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This was possibly due to a reaction between the thioether and a neighbouring
α-bromoamide, forming a salt. The compound was not included in further
synthesis.
Figure 3.4.: First synthetic step
3.3. Modifications to the Toma procedure
In the second step, the original procedure (Route A) used the amidine base DBU
to deprotonate the N,N’-ditosylhydrazine and subsequently the adduct with the
amide, that resulted from the nucleophilic attack of the hydrazine anion on the
α-carbon (cf. figure 3.3 on the preceding page). The similar base strength of TMG
(cf. table 1.1 on page 7) and its properties as a nucleophilic catalyst,37a made it an
interesting alternative to DBU. The route employing TMG is route B in figure 3.1
on page 27.
In the original procedure, the crude reaction mixture was quenched with
NaHCO3(aq) and then extracted with Et2O. In our experience - assuming that
the mechanistic proposal is accurate - it was problematic to perform a clean ex-
traction due to the presence of the 4 molar equivalents of DBU−HO2S-C6H4CH3
and 1 equivalent of DBU−HBr. This situation manifested itself more gravely on
a reaction scale > 5 mmol. The problem could lie in the intermediate solubility
of the DBU−HO2S-C6H4CH3 complex between the aqueous phase and the
ether phase. What further complicated the matter of an aqueous extraction
procedure, was the aqueous solubility of the obtained α-diazoacetamides. The
aqueous phases had to be thoroughly extracted to obtain decent yields, which
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also increased the solvent expenditure. Yields of 50 - 60 % were obtained over
two steps, however the reaction mixtures were discoloured and the number of
extractions imposed limitations of the reaction scale.
Figure 3.5.: Second synthetic step
3.4. Results of the modifications
When the reaction was run with TMG instead of DBU, a quick, clean reaction
was observed and after stirring for a period of approximately 60 minutes, a
heavy precipitate formed, which settled to reveal a bright yellow solution when
stirring was stopped. The THF was then removed under reduced pressure and
Et2O added. Vigorous stirring left a suspension which could then be filtered
with suction to give transparent bright yellow solution, leaving behind an almost
white filter cake. By NMR the filtrate consisted chiefly of the product (cf. crude
NMR of 1c in the appendix).
To obtain the α-diazoacetamides with sufficient purity for an investigation of
their halogenation, chromatography was carried out on silica gel. Chromatog-
raphy on alumina, both neutral and basic, appeared to be detrimental to the
compounds, based on observed surges of bubbles from within the column in
the middle of elution. Worthy of note, is the effect of the almost complete
removal of the produced TMG ·HO2S-C6H4CH3 by filtration of the precipitate.
This simplified the chromatography considerably, allowing the columns to be
fairly heavily loaded, e.g. 2.6 g of 3c was isolated from an 8.5 × 3.5 cm column
34
The precipitated TMG ·HO2S−C6H4CH3/TMG ·HO3S−C6H4CH3
of standard silica gel. The elution needed to be slow in order to achieve
separation from a common by-product with a slightly lower R f value, which is
the α-tosylacetamide. This compound was also observed in the publication by
Toma et al.31a and its formation can be rationalized by the nucleophilic attack on
the α carbon of the unreacted α-bromo amide by the sulfur atom in the sulfinate
group. A reaction summary is presented in figure 3.5 on the facing page and
the experimental details for all the compounds can be found in the experimental
section (section 9 on page 79)
3.5. The precipitated
TMG ·HO2S−C6H4CH3/TMG ·HO3S−C6H4CH3
The precipitated TMG ·HO2S-C6H4CH3 merits further discussion. The salt is a
free-flowing white powder, which becomes hygroscopic as the sulfinic acid is
oxidized to sulfonic acid in air. A sample left exposed to air, became a sludge
after about a month, presumably due to water solvation. The salt is highly
soluble in H2O, CH2Cl2, CHCl3, MeOH and MeCN, but has limited solubility
in THF and almost none in Et2O. The composition of the salt was probed by
mass spectrometry (ESI) and by growing crystals suitable for X-ray diffraction
studies. The MS sample was isolated from a freshly filtered batch, and dried and
stored under argon until the spectra could be recorded. Already at this point,
some sulfonic acid could be detected. This, most likely owes to the reaction being
conducted in an air atmosphere.
The crystals of TMG ·HO2S-C6H4CH3 grew while storing a MeCN solution
at 4 °C overnight, whereas the TMG ·HO3S-C6H4CH3 were grown by exposing
a sample of TMG ·HO2S-C6H4CH3 to air for several days before submitting
it to crystallization from CH2Cl2/Et2O. The molecular arrangement is similar
in both crystals and involve two molecules of base and two of acid. This
was corroborated by the observation of the TMG ·TMG ·HO2S-C6H4CH3 and
TMG ·TMG ·HO3SC6H4CH3 fragments in the mass spectrometer (MS-ESI). The
structures are shown in figures 3.6 and 3.7 on the following page.
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Figure 3.6.: Structure showing intermolecular hydrogen bonding in the crystal of 1,1,3,3-
tetramethylguanidine sulfinate. The data were recorded at 105 K. Displacement
ellipsoids are shown at the 50 % probability level with hydrogen atoms as spheres
of arbitrary size.
Figure 3.7.: Structure showing intermolecular hydrogen bonding in the crystal of 1,1,3,3-
tetramethylguanidine sulfonate. The data were recorded at 296 K. Displacement
ellipsoids are shown at the 50 % probability level with hydrogen atoms as spheres
of arbitrary size.
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3.6. Previously unreported α-diazoacetamides
Of the α-diazoacetamides that were prepared, some were described in the
literature, but the experimental details concerning their preparation were rather
scarce. Most frequently, the compounds had been prepared by the reaction of the
amine with succinimidyl diazoacetate. Of the known compounds were 1c,37b,37i
2c,27b,32a,33b,37c,37d,37e,37f,37h 3c,37h and 6c.32a,33b,37j
Since the three remaining analogues were unknown,15 crystals suitable for X-
ray crystallography were grown and low temperature diffraction data (105 K)
recorded to unequivocally determine the structures of 4c, 5c and 8c. The
structures and intermolecular bonding present in the crystals are shown in figure
3.8 and in 3.9 and 3.10 on page 39, respectively.
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Figure 3.8.: Structure showing intermolecular hydrogen bonding in the crystal of tert-butyl
4-(2-diazoacetyl)piperazine-1-carboxylate (4c). The data were recorded at 105 K.
Displacement ellipsoids are shown at the 50 % probability level with hydrogen atoms
as spheres of arbitrary size
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Figure 3.9.: Structure showing intermolecular bonding in the crystal of N,N’-bis(2-
diazoacetyl)piperazine (5c). The data were recorded at 105 K. Displacement
ellipsoids are shown at the 50 % probability level with hydrogen atoms as spheres of
arbitrary size
Figure 3.10.: Structure showing intermolecular hydrogen bonding in the crystal of 2-diazo-1-
(1,1-dioxido-4-thiomorpholinyl)ethanone (8c). The data were recorded at 105 K.
Displacement ellipsoids are shown at the 50 % probability level with hydrogen atoms
as spheres of arbitrary size
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4. The synthesis and reactivity of
α-halodiazoacetamides
α-halodiazoacetic esters have been utilized in dirhodium(II) catalyzed cyclo-
propanations, C−H and Si−H insertions, showing that they are indeed compe-
tent reactants in reactions common in the field of metal carbenoids.26a,10h Addi-
tionally, they have been photolyzed to give the corresponding carbenes which
underwent cyclopropanation and C−H insertion reactions.10f They are reported
to be highly kinetically active, when used in rhodium catalyzed reactions.26a,10h
This can be interpreted as an expression of the low energy barrier towards the
rate-limiting nitrogen extrusion step. It should also indicate that their ground
state lies quite high in energy. Thus, for the first attempts to synthesize the
α-halodiazoacetamides, we decided to direct our attention to the brominated
analogue, as it was expected to be a slightly more chemically stable compound
than the chlorinated analogue.10d
4.1. First impressions
Our first attempts to synthesize the α-bromodiazoacetamide derived from
2c, were carried out using the reported methodology.10h The reaction itself
proceeded in the expected way; the colour change from bright yellow to bright
red upon adding the halogen source is complete within a few minutes. It
was observed, however, that a lower temperature and less handling (washing,
transferring) was necessary to assure the reproducibility. As measures to achieve
this, a cryostat was employed to secure a reaction temperature of −5 °C,
quenching (Na2S2O3(aq)) and drying (MgSO4) were omitted, and the short
column used to separate the brominated α-diazoacetamide from the base and
remaining scaffold of the N-bromo source, was built into a holder which could
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be filled with CO2(s), giving a temperature of approximately −80 °C during
the quick chromatographic step. The results of these modifications appeared
satisfactory, judging by the colour of the solution eluted from the column (bright
red). It was also possible to analyze the reaction by thin layer chromatography
(TLC) in a cooled chamber. Judging by the plate, the conversion of 2c to 2d was
high, if not complete.
The first attempts to cyclize 2d were carried out with dirhodium(II) catalysis
using commercial Rh2(esp)2 and the synthesized Rh2(OAc)2(pc)2 · 2 MeCN
(pc = orthometalated PPh3). To our satisfaction, the product was visible by 1H-
NMR, but the yields were low (10 - 30 %). In the 1H-NMR, carbene dimerization
products, but also the corresponding α, α′-Br2-piperidine acetamide, were the
other major species.
The fact that the product had formed, was interesting as previous attempts
by others,37h although with the essentially different 2c, catalyzed by chiral
dirhodium(II) carboxamidates, did not yield any product. The workers in the
mentioned publication, did however obtain high yields of the β-lactam derived
from 3c, which held promise for our later attempts with this substrate. Although
the substituents are sterically and electronically distinct, the formation of the
β-lactam indicated that the halogen substituent was comparable to a phenyl
group, at least in the sense that their carbenes/carbenoids in fact achieve the
cyclization (cf. discussion in section 2.4.1 on page 22). The electronic effects of the
halogen substituents on α-halodiazoacetic esters in comparison to other common
substituents in the context of dirhodium(II) catalyzed cyclopropanations, has
been investigated computationally by our group.26b
Incidentally, the rest of an incompletely eluted short column was left on
the bench in ambient temperature, out of curiosity to see what would happen
if the α-bromodiazoacetamide was allowed to “decompose” by itself. Our
expectation to obtain a crude reaction mixture which would not contain
any product, was confused by the fact that although thermolysis of diazo
compounds is indeed a common route to synthetically competent carbenes,
it had not before been done with the heat available at ambient temperature.
What the 1H-NMR showed, was ironical to anyone working with transition
metal catalysis; Complete conversion, with almost complete chemoselectivity
for the intramolecular β-lactam formation, had occurred. A subsequent trial
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was immediately set up and a few hours later the result was reproduced. The
chemoselectivity of the C−H insertion reaction, was marginally compromised
by the formation of carbene dimerization products and a small amount of the
α, α′-Br2−amide.
4.2. Optimization studies
Figure 4.1. – 2 mmoles of 2d un-
dergoing thermolysis. The septum is
perforated with a cannula and is only
present to avoid evaporation.
With this reaction in hand, we could pur-
sue the optimization of the conditions of
formation of the α-bromodiazoacetamide 2d
from 2c. We had learned from the first
attempts and from the syntheses of the
α-diazoacetamides, that alumina was too
active to be used as a chromatographic
medium. We proceeded to investigate the
effect of dilution on the reaction of 2d −→ 2e.
The results, which can be seen in ta-
ble 4.1, indicate that within the concen-
tration range we examined, there was no
good reason to increase the solvent expendi-
ture.
Table 4.1.: Yieldsa of trans-7-bromo-1-azabicyclo[4.2.0]octan-8-one obtained by
varying the reaction concentration in the thermolysis of 2d
Reaction volume (mL) Concentration (mM) Yield (%)
50 10 50
100 5 51
300 1 23 54
a Determined by 1H-NMR,38 0.5 mmol reaction scale
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We then investigated the effects of different bases and bromine sources, as
discussed in section 1.3 on page 7. The reaction conditions are shown in figure 4.2
on the next page and the results can be found in table 4.2 beneath the figure. The
reaction times were not optimized, which could mean that e.g. TMG may serve
as well as DBU with longer reaction times. In general, the yields were uplifting,
considering the results from the dirhodium(II) catalyzed reactions.
4.3. Results of the thermolysis of 1d-6d and 8d
Under the reaction conditions, both NBS and NBP provided clean products,
according to spectral analysis. It was, however, possible to trace both succinimido
and pththalimido species by 1H-NMR (cf. the crude spectra corresponding to
NBS and NBP in the appendix), and this caused some worry as to whether the
failure of the dirhodium(II) catalysis might be attributed to an inhibition of the
catalyst active site by these species. By TLC analyses however, it seems probable
that these species are unreacted NBS or NBP, given the relatively high R f of the
α-bromodiazoacetamide 2d with which they coelute. Fortunately, they do not
seem to have a negative impact on the intramolecular C−H insertion reaction,
by what must be presumed to be the “free“ α-bromocarbene amide.20k With this
reasoning, the conditions providing the highest yields (DBU/NBP), were applied
to the analogues 1c - 6c and 8c. A reaction scheme can be seen in figure 4.3 on
page 46 and the results are displayed in table 4.3 on page 47.
As can be seen in table 4.3 on page 47, the reaction is apparently more difficult
for rings with less conformational freedom. The total yield thus decreases with
decreasing ring size, especially when moving from the six-membered to the
five-membered ring, plausibly reflecting the increasing strain in the bibcyclic
system (cf. the yields of 1e vs. 2e vs. 3e and note d below the table). Focusing
on the six-membered rings, the introduction of a heteroatom clearly restrains
the conformational freedom, as thus the ease with which the carbene is able to
form the β-lactam. Additionally, comparing the higher yield of 4e vs. 6e and 8e, it
seems possible that other carbenic pathways may be operating. The ether oxygen
in 6e and the sulfonyl oxygens in 8e could possibly take part in ylide formations,
which would lower the yield of the β-lactam products. Crude spectra from the
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Figure 4.2.: The reaction conditions in the bromination of the α-diazoacetamides
Table 4.2.: Yieldsa in % of trans-7-bromo-1-azabicyclo[4.2.0]octan-8-one (2e),
obtained by varying the base and bromine source
NBPy NBS NBP NBSa
DABCOb - d 43 37 - e
TMGc 33 41 51 - e
DBUc 65 56 73 - f
TBDc - e - f - f - f
a Determined by 1H-NMR,38 0.5 mmol reaction scale
b The reaction time was 30 minutes
c The reaction time was 5 minutes
d No appreciable reaction progress was observed after 30 minutes
e Rapid gas evolution and loss of colour were interpreted as signs of
decomposition
f The reaction was not carried out as the reagent combination was
considered unsuitable based on the related results
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Figure 4.3.: The reaction sequence from α-diazoacetamide to α-bromodiazoacetamide to β-lactam
six reactions are shown in the appendix, and it is notable that the more highly
functionalized analogues, do not react as cleanly as 2d and 3d.
Nonetheless, the reaction 3d −→ 3e shows how well the α-bromocarbene
amide C−H inserts in the absence of steric or conformational hindrance. A
larger scale reaction of 3c −→ 3e (2 mmoles of 3c) was undertaken successfully.
The yield after chromatography (used to separate the diastereomers) is reported
in parentheses in table 4.3 on the next page. The spectra of the crude and
chromatographed products, as well as other pertinent details, are found in the
appendix and the experimental section (section 10.3 on page 102).
The doubly diazoacetylated analogue 5cwas also brominated and thermolyzed
using the same conditions. It appeared that the compound could be brominated
similarly to the other analogues, judging by the colour change, but the 1H-
NMR and the mass spectrometry data (ESI) of the crude reaction mixture, were
largely uninterpretable. Given the variety of products that could result from
one or two intramolecular C−H insertions, let alone dimerization reactions and
intermolecular reactions, this result was not unexpected.
Finally, a variation which is difficult to justify is that of the yields of
the α, α′-Br2−amides. They are known products from the reactions of diazo
compounds and molecular halogen,15 yet here it seems unlikely that they are
formed in the bromination step; The large variation in their yield and the inverse
covariation with the product yield (R2 = 0.84, see figure 4.4 on page 48), could
suggest that they are somehow derived from the α-bromocarbene amides or their
α-bromodiazoacetamide precursors. The α, α′-Br2−amide of piperidine has been
characterized by 1H-NMR (cf. section 10.2.1 on page 102 and the spectrum in the
appendix).
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Table 4.3.: Yieldsa in % of β-lactam obtained from the thermolysis of the α-bromodiazoacetamides
Reaction trans cis
trans/cis
ratiob Total
α, α′-Br2-
Amide
7 - c n/a 7 d 34
73 11 6:1 84 2
77
(81)e
16
(13)e
5:1
(6:1)e
93
(94)e
trace
(–)
34 2 17:1 36 21
12 1 6:1 13 20
14 3 5:1 17 12
a Determined by 1H-NMR38
b Rounded off to the nearest whole number
c Not detected by 1H-NMR
d Upon taking a new 1H-NMR spectrum of the reaction mixture after approximately 48 hours (as has
been done routinely to verify the yield measurements), 38 the characteristic doublet used to measure the
yield was no longer present, indicating that the compound had decomposed; possibly by hydrolysis.27b
e Isolated yield after chromatography. The α-bromodiazoacetamide precursor was prepared using DBU
and NBS (cf. table 4.2 on page 45)
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Figure 4.4.: A plot of the yield of the α, α′-Br2−amides vs. the total yield of the β-lactams for each
analogue.
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4.4. A comparison of the thermolytic and catalytic
reactions, employing three prototypical transition
metal catalysts
Having obtained the thermolysis results, we turned back to verify the results
with the dirhodium(II) catalysts. This time we chose two dirhodium(II) catalysts
from two entirely different families; Rh2(tfa)4, one of the most Lewis acidic
catalysts available and its extreme opposite, the Rh2(cap)4. A copper(II) catalyst
Cu(acac)2 was also included in the interest of exploring the reactivity of the
α-bromodiazoacetamides with this family of catalysts. Finally, the best result with
the Rh2(OAc)2(pc)2 · 2 MeCN (pc = orthometalated PPh3) and with thermolysis
using the DBU/NBS conditions, were included for comparison (an average of
5 such thermolysis reactions are included in parentheses). The results of the
catalytic dediazotization of 2d are shown in table 4.4 on the following page.
A methodological problem arises, when it is known that the α-bromodiazoacet-
amides selectively form the desired product upon thermolysis, and the reported
optimal conditions for catalysis with α-bromodiazoacetic ethyl ester26b (used
here as a guideline), involve letting the solution of the α-bromodiazoacetic ethyl
ester warm up to room temperature before injecting a solution of the catalyst.
Fortunately, studying table 4.4 on the next page, reveals that the result with the
copper(II) catalyst, disappointing nonetheless, serves to inform of a bottom line
which hardly contains any product. The crude 1H-NMR spectrum shows a near
complete conversion to the formal carbene dimer (cf. spectrum in the appendix),
a result which attests to the efficiency of the catalyst, although not in the desired
pathway. In spite of this, there is in principle no way of rigorously excluding
the possibility that the thermolysis pathway is operational under the described
conditions.
The other three catalysts produce the product in low yields alongside dimeric
products. It is interesting to see the small difference, in this reaction, between
the two catalysts Rh2(tfa)4 and Rh2(cap)4, that show such distinct reactivity with
other substrates. Rh2(tfa)4 is reported to give results in selectivity experiments,
that indicate that it, to some extent, releases the free carbene.23a In such a
situation, the yield produced by the ”free” carbene would add to the yield
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produced by the metal carbene complex, the consequence being that the noted
yield with Rh2(tfa)4 becomes higher than it should. If this is the case, it is
tempting to propose, at the risk of being mistaken about the time scales on which
the reaction operates, that the higher yield using Rh2(cap)4, can be attributed to
a carbene complex which is sufficiently stabilized to experience a higher number
of viable conformations in which to C−H insert. This proposition, however, goes
unsubstantiated (cf. discussion in 2.4 on page 21).
Table 4.4.: Yieldsa in % of trans/cis-7-bromo-1-azabicyclo[4.2.0]octan-8-one obtained from the
catalytic dediazotization of 2d. Thermolysis result is shown for comparison.
Catalyst
Nominal
catalyst loading
(% mol) trans cis
trans/cis
ratio Total
α, α′ − Br2-
Amide
Cu(acac)2
b 3 2 - c n/a 2 2
Rh2(tfa)4
b 3 22 6 3.7:1 28 25
Rh2(OAc)2(pc)2
b 1 30 4 7.5:1 34 10
Rh2(cap)4
b 3 38 6 6.3:1 44 14
None (thermolysis)b n/a 57 (55)d 10 5.7:1 67 3
a Determined by 1H-NMR38
b DBU/NBS bromination conditions
c Not detected by 1H-NMR
d Averaged over 5 reactions under nearly equal conditions
4.5. Synthesis and thermolysis of α-chloro- and
α-iodo-4c
It was desirable to investigate whether the reaction of the α-bromodiazoacetamide,
could be extended to its chlorine and iodine analogues. 4d was chosen as the
model compound, because its insertion reaction with bromine gave a moderate to
low yield, which provided an opportunity for its chlorine and iodine analogues
to expose their differential reactivity. The halogenation reactions were carried
out using DBU/NXS (X = Cl, Br, I) and proceeded similarly to the bromination
reactions.
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Table 4.5.: Yieldsa in % of trans/cis-tert-butyl 7-halo-8-oxo-1,4-
diazabicyclo[4.2.0]octane-4-carboxylate X-4e (X = Cl, Br, I) obtained
from the thermolysis of α-chloro-, α-bromo- and α-iodo-tert-butyl 4-(2-
diazoacetyl)piperazine-1-carboxylate
Compound trans cis
trans/cis
ratio Total
Cl-4e 10 2 5:1 12
Br-4eb 34 2 17:1 36
I-4e 2 - c n/a 2
a Determined by 1H-NMR 38
b This run is independent of the run in table 4.3 on page 47
c Not detected by 1H-NMR
As can be observed from the table 4.5, the bromine analogue appears to be
the most efficient of the substituents for this reaction. The lower yields with
both the other analogues are unexpected, based on the results with the three
halogen analogues in cyclopropanation reactions.10h Additionally, the result with
the iodine analogue might not be representative; During the preparation of the
α-iodo-4d, the coloured solution assumed to contain the α-iododiazoacetamide,
eluted from the short column as normal, but did not loose its colour upon
standing in ambient temperature for a period of 24 hours. After this time, the
solvent was evaporated to give the result seen in table 4.5. Normally, the intense
red colour of the α-bromodiazoacetamides disappears to leave a transparent
solution within ~ 60 minutes. This could indicate that the result of thermolysis of
I-4d is not valid.
4.6. The scope of the thermolysis reaction beyond the
intramolecular C-H insertions
It seemed of interest to substantiate whether the thermolysis reactions of
α-halodiazoacetic esters and amides have a potential outside the scope in which
they have been used in this work. Thus, EDA was brominated following the
published procedure,10h styrene was added and the CH2Cl2 evaporated to give
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the α-bromo-EDA dissolved in styrene. The solution was left to thermolyze
for a few hours at ambient temperature. Then, one crystal of the radical
inhibitor hydroquinone was added to keep the styrene from polymerizing, while
evaporating the styrene under reduced pressure at 30 °C. The residue was run
through a plug of silica gel before determining by 1H-NMR38 that the reaction
had afforded a 42 % yield of ethyl 1-bromo-2-phenylcyclopropanecarboxylate
(trans:cis/1.2:1). Although not the excellent yield (91 %, trans:cis/9:1) obtained
with dirhodium(II) catalysis,10h the result holds promise for the development of
a catalyst-free route to the racemic cyclopropanes in question.
In the same vein, 4d was thermolyzed in styrene and although the reaction
outcome was not quantified, the cyclopropane signals in the recorded 1H-NMR
spectrum are clearly visible. A trace amount of β-lactam can also be seen.
The 1H-NMR spectra for both of these reactions are included in the appendix.
A further exploration of the range of carbenic transformations in which the
α-bromocarbene esters and amides will take part, is a natural extension of this
work.
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5. A synthetic outlook for the
α-bromo-β-lactams
Below are two brief discussions on ideas that were conceived during the planning
of this work. One seeks to improve the methodology of synthesis and ease of
isolation of the thermolabile halogenated diazo compounds, while the other
brings the α-bromo-β-lactams further by making use of the structural complexity
created by the C−H insertion reaction.
5.1. Polymer-supported N-halo reagents
Given the lability of the α-halodiazocarbonyl compounds, their method of
preparation and isolation could benefit from the use of immobilized reagents.
In the halogenation reaction described in this work, the exchange of the
monomeric N-halo reagent for a solid phase reagent would likely be the
most beneficial modification. Of the N-halo reagent scaffolds mentioned in
section 1.3.2 on page 8, several have been immobilized on polymer supports,
among them amides, imides and sulfonamides. Commonly, this is achieved by
copolymerization of feedstock monomers like methacrylamide with a crosslinker
and suitable comonomers. Many of these preparations have been reviewed.18f,16a
The polymeric material thus obtained, must then be treated with e.g. aqueous
hypohalites to give the N-halo polymers. Given that the halogenation reaction
with a given solid phase reagent proceeds similarly to the reaction with the
monomeric reagents, the work-up procedure would be simplified, requiring
only to separate the highly polar base from the produced α-halodiazocarbonyl
compound, after filtering off the polymeric material. This separation could be
achieved using a cooled short column, as done in this work.
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5.2. Coupling with indole structures
Assuming that the α-halo-β-lactams are fairly hydrolytically stable, and not
active inhibitors of β-lactamase, they would seem to have little future as penicillin
analogues. Consequently, the employment of their structural features must be
reviewed. In the beginning of this work, the idea was conceived that the amide
nitrogen in the α-halo-β-lactams could be used as a source of a “biogenic
amine“ in the synthesis new compounds similar to known neurotransmitters
in the tryptamine family (including serotonin), by the coupling of the α-halo-
β-lactams and the 3-position of substituted indole structures. The coupling
can be accomplished using the potential coupling point, constituted by the
α-halocarbonyl moiety, which is presumably a potent electrophile with respect
to the α carbon.
The coupling ideally establishes a two carbon distance between an indole
aromatic system and the amide nitrogen, which upon either reduction of the
carbonyl group, or hydrolysis, becomes an amine. The resulting structures
contain highly conserved motifs that are found in many endogenous and
synthetic agonists and inverse agonists of class A G-protein coupled receptors
(GPCRs) throughout the body (e.g. the serotonin receptors).
To create variation in the side chain, while maintaining the ”privileged”
indole moiety in its endogenous form, is sensible because it is the aromatic
moiety, together with the amine nitrogen itself, which are the most highly
conserved elements, and that confer the general compatibility with this class of
receptors. Variations in the side chain and its substituents, are in turn thought
to confer selectivity through interactions with residues in the binding pocket
whose arrangement is subtype-specific. The utilization of motifs that are highly
conserved, can also be a route to multipotent drugs (dirty drugs), that is
compounds with activity in more than one receptor subtype.39
The necessary coupling can be achieved through a polar pathway,28e or
perhaps more likely, a radical pathway.40 There is also the possibility of using
transition metal catalyzed cross-coupling methodology.
An outlook to target compounds in the proposed coupling strategy and
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beyond is shown in figure 5.1 on the next page. In the figure, two pathways to
render the free amine after coupling are proposed, as well as an alternative use
of the amine, resulting in structural analogues of ergoline:
A A hydrolytic pathway
(to beta-tryptophan analogues)
B A hydrolytic pathway followed by Buchwald-Hartwig amination
(to 10-azaergoline derivatives)
C A reductive pathway
(to caged-amine analogues of tryptamine and serotonin)
Of the compounds listed in figure 5.1 on the following page, very few are
reported.15
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Part III.
Experimental Procedures and
Physical Data

6. General introduction to the
experimental section
All commercially available reagents and solvents were used as received except in
the cases where purification was necessary to ensure the purity of a reagent. The
CH2Cl2 used in the acylation of the amines and in the dediazotization reactions
was obtained from an MBraun MB SPS-800 solvent purification system and is
dry, but more importantly free of alcoholic stabilizers. Regular, stabilized CH2Cl2
does not inhibit the reactions in question, but traces of ethyl esters (O-acylation)
and ethyl ethers (carbene O-H insertion product) have been been observed
spectroscopically when running the reactions in stabilized CH2Cl2.
The prepared N-bromo compounds and diazo compounds were stored in a
freezer at −20 °C to ensure their integrity and were left in ambient temperature
for about 5 minutes before exposing them to air in order to minimize weighing
errors caused by condensed water.
Except for the above stated routine, no special precautions were taken to
exclude air or airborne moisture at any point during the syntheses described
in this work, except in the acylation reactions where it was clearly detrimental.
Inert atmosphere (Ar or N2) is used only where stated specifically (acylations,
catalyzed reactions and free radical polymerization reactions). Stirring refers
to magnetic stirring in all the procedures. Heating was performed with
fluoropolymer-coated all-metal heating mantles.
Chromatography was performed on silica gel (Merck 60, 40-63 µm) and
thin layer chromatography (TLC) on aluminium sheets coated with silica gel
(Fluka 6607780, 20 mm, fluorescent coating for 254 nm) or neutral alumina
(Macherey Nagel Alugram Alox N, 0.20 mm, unactivated, no fluorescent
coating). The plates were visualized with KMnO4, K2CO3 and NaOH in water
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for the α-bromo amides (alumina) and UV-light and/or a solution of p-
anisaldehyde, concentrated H2SO4 and glacial CH3CO2H in 96% EtOH for the
α-diazoacetamides (silica gel), followed by heating with a heat gun for both. The
β-lactams (alumina) were visualized with a solution of ninhydrin and pyridine in
absolute EtOH followed by heating or with a solution containing AgNO3, H2O,
2-phenoxyethanol, acetone and H2O2 (30 %, aq) followed by exposing the plate
to UV-light for about 10 minutes.
Nuclear magnetic resonance (NMR) spectroscopy was performed on Bruker
DXP200/DXP300 spectrometers operating at 200/300 MHz for 1H and 75/50
MHz for 13C, and on a Bruker DXP200 operating at 81 MHz for 31P. The chemical
shifts are reported in parts per million (δ) relative to the residual solvent signal
in general accordance with the literature:41 δ-1H/δ-13C (Solvent); 7.26/77.00
(CDCl3), 5.32/53.80 (CD2Cl2), 2.50/39.52 (DMSO−d6) and 1.94/118.26 (CD3CN).
Chemical shifts are given in the section for physical data for each compound.
Additionally, the spectra for the reported compounds are included in the
appendix where their signals are assigned to numbered structures appearing
on each spectrum, based on the information gained from the performed NMR
experiments. The NMR data were processed with ACD/Labs NMR Processor
Academic Edition.
Mass spectrometry experiments were carried out with a Fisons VG ProSpec
for electron impact ionization (EI) and a Micromass Q-TOF 2 or a Bruker Apex
FTMS (FT-ICR, 4.7 T) for electrospray ionization (ESI). The results from the two
instruments are marked (ESI, Q-TOF) and (ESI, FT-ICR), respectively. The solvent
used and other essential details are noted in each case.
Melting points were taken a Stuart SMP10 (Barloworld Scientific Ltd., UK).
X-ray diffraction crystallography was performed using a Bruker axs Smart
Apex II CCD D8 diffractometer with an installed temperature control system.
Coordinates were refined for H-atoms involved in H-bonding. Other H-atoms
were positioned with idealized geometry. The available crystallographic data
for the unpublished structures are included in the appendix, as well as the
publication of the structure of 4c.
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7. Synthesis of N-bromo compounds
and N,N’-ditosylhydrazine
7.1. N-bromo-2-pyrrolidone
N-bromo-2-pyrrolidone was prepared by extending a procedure published by
Souza et. al42 for the preparation of N-chloro- and N-bromosaccharin. The
original procedure is modified by an additional 0.25 eq of Na2CO3.
2-pyrrolidone is freely soluble in water and the reaction proceeds with only
barely visible yellow/orange colour of free bromine upon addition of the oxidant
(see the synthesis of N-Bromosaccharin for some general details about the
reaction).
The N-bromo-2-pyrrolidone was recrystallized from EtOAc/Et2O (2:1). It is
apparently stable in the dark at −20 °C and no appreciable yellowing occurred
over months of storage, however at 4 °C this occurs over weeks, which is in
coherence with the literature.43 The IR spectrum is in accordance with that
published by Parsons.44
7.1.1. Experimental procedure
2-pyrrolidone (17.50 g, 205.7 mmol, 1.0 eq), Na2CO3 (16.36 g, 154.3 mmol, 0.75
eq) and KBr (24.47 g, 205.7 mmol, 1.0 eq) were added to a 1000 mL round
bottom flask followed by H2O (Type II, 300 mL). The flask was cooled on an
ice/water bath for 5 minutes, after which potassium peroxymonosulfate (as
its triple salt 2 KHSO5 ·KHSO4 ·K2SO4, oxone®) (126.5 g, 205.7 mmol, 1.0 eq)
61
Synthesis of N-bromo compounds and N,N’-ditosylhydrazine
suspended in H2O (Type II, 200 mL) was added in small aliquots, with vigorous
stirring (700 pm), over a period of 10 minutes. The colour change towards yellow
for each addition was minimal and the solution rapidly turned back into a
white suspension. Care was taken towards the end of the addition, as the white
suspension frothed and increased its volume for each addition. The cooling bath
was removed and the flask wrapped in aluminium foil, allowing the suspension
to stir in the dark for period of 19 hours. The light yellow suspension was
extracted with CH2Cl2 (8 × 50 mL), and the combined organic phases evaporated
under reduced pressure, at or below ambient temperature, leaving a white solid.
The solid was dissolved in EtOAc (100 mL) and Et2O (50 mL) was added without
the solution becoming turbid. Upon standing overnight the solution deposited
10.87 g (32 %) of clear prisms (1 × 1 mm – 3 × 3 mm).
7.1.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.58 – 3.00 (m, 2H), 2.36 – 2.26 (m, 2H), 2.24 –
2.09 (m, 2H)
• 13C-NMR (75 MHz, CDCl3) δ 174.2, 53.3, 26.5, 19.8
• Melting point: 95 – 100 °C (EtOAc/Et2O, melting, then decomposition)
(lit. 95 °C43)
• FTIR (KBr) ν˜/cm−1 (intensity); 3320 (w), 2986 (m), 2963 (m), 2925 (m), 2894
(m), 1685 (vs), 1653 (vs), 1486 (m), 1451 (m), 1383 (s), 1258 (s), 1223 (m), 1204
(m), 1174 (m), 1122 (m), 1015 (m), 923 (w), 817 (m), 708 (m), 623 (m), 553 (w),
530 (m)
7.2. N-bromosuccinimide
N-bromosuccinimide was purchased from Sigma-Aldrich and recrystallized
from boiling water to give thin transparent plates in accordance with the
literature.45
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7.3. N-bromophthalimide
N-bromophthalimide was prepared from phthalimide by extending a proce-
dure published by Souza et. al42 for the preparation of N-chloro- and N-
bromosaccharin. The original procedure is modified by an additional 0.25 eq of
Na2CO3 (see the synthesis of N-Bromosaccharin for some general details about
the reaction).
The reaction proceeds noticeably slower than in the case of sodium saccharin
or 2-pyrrolidone, possibly due to the fairly low solubility of phthalimide even
in basic water. Another consequence of this is a prolonged and more visible
release of bromine. As the consumption of the released bromine is slower than
with saccharin, it is necessary to close the reaction vessel with a glass stopper to
contain the evolution of bromine gas. The yield was 65 %, comparable to the yield
of N-bromosaccharin. The obtained spectroscopic data were in correspondence to
published data, although with a lower melting point, possibly owing to the fact
that the recrystallization from toluene left a slightly amorphous crystal mass.
7.3.1. Experimental procedure
Phthalimide (7.36 g, 50.0 mmol, 1.0 eq), Na2CO3 (3.98 g, 37.6 mmol, 0.75 eq)
and KBr (5.95 g, 50.0 mmol, 1.0 eq) were added through a solid addition funnel
to a 500 mL round bottom flask followed by H2O (Type II, 200 mL). The
flask was cooled on an ice/water bath for 10 minutes, after which potassium
peroxymonosulfate (as its triple salt 2 KHSO5 ·KHSO4 ·K2SO4, oxone®) (30.8
g, 50.1 mmol, 1.0 eq) suspended in H2O (Type II, 75 mL) was added in small
aliquots, with vigorous stirring (700 rpm), over a period of 10 minutes. The
addition of the oxidant resulted in vigorous release of bromine gas, and thus the
flask was capped with a glass stopper between additions. The mixture quickly
turned into an orange spongelike suspension with visible bromine gas above
it. The suspension was left to stir for 24 hours, at which point it had become
a yellow solution with a white precipitate. Stirring was continued another 24
hours, until the solution above the precipitate was almost clear. The suspension
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was filtered on a Büchner-funnel and the filter cake sucked dry for a period of
30 minutes. The white precipitate was dissolved in boiling toluene (150 mL), hot
filtered into a beaker and left to cool slowly to ambient temperature, covered
with an aluminium foil. Upon reaching ambient temperature, precipitation had
begun and the beaker was placed in a refrigerator at 4 °C for a period of 17 hours,
before filtering the precipitate on a Büchner-funnel. The filter cake was washed
with n-pentane (30 mL) to give 6.52 g (57 %) of small white crystals. The mother
liquor was concentrated, filtered and the filter cake washed with toluene (5 mL)
and n-pentane (10 mL) to give 0.91 g (8 %). Both crops were of equal purity by
1H-NMR. The total yield was 65%.
7.3.2. Physical data
• 1H-NMR (200 MHz, CDCl3) δ 7.95 – 7.81 (m, 2H), 7.81 – 7.68 (m, 2H) (Ref.46)
• Melting point: 176 – 184 °C (C6H5CH3, decomposition)
(lit. 199 – 200 °C,46 CH2Cl2)
7.4. N-bromosaccharin
N-bromosaccharin was prepared in 55 % yield following a procedure published
by Souza et. al42 in which bromine is generated in situ by oxidation of KBr in
water. The spectroscopic data obtained was in accordance with that published.
7.4.1. Experimental procedure
Sodium-saccharin (8.21 g, 40.0 mmol, 1.0 eq), Na2CO3 (2.12 g, 20.0 mmol, 0.5
eq) and KBr (4.77 g, 40.1 mmol, 1.0 eq) were added through a solid addition
funnel to a 250 mL round bottom flask followed by H2O (Type II, 100 mL). The
flask was cooled on an ice/water bath for 10 minutes, after which potassium
peroxymonosulfate (as its triple salt 2 KHSO5 ·KHSO4 ·K2SO4, oxone®) (24.6
g, 40.0 mmol, 1.0 eq) suspended in H2O (Type II, 80 mL) was added in small
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aliquots, with vigorous stirring (700 rpm), over a period of 10 minutes, and
the flask loosely capped with a glass stopper. During the addition the clear
solution turned to a yellow and then orange voluminous suspension. The colour
returned to light yellow as the released bromine was consumed. The cooling
bath was allowed to melt and stirring was continued for period of 23 hours. The
suspension was filtered on a Büchner-funnel and the filter cake washed with H2O
(Type II, 2 × 100 mL), leaving a white powder. The powder was dried in the dark
in a fume hood for 24 hours after which it weighed 5.77 g (55 %)
7.4.2. Physical data
• Melting point: 174 – 180 °C
(lit. 165 – 167 °C,42 170 – 172 °C47)
• FTIR (KBr) ν˜/cm−1 (intensity); 3404 (w), 3094 (m), 3072(w), 1709 (vs), 1671
(m), 1637 (m), 1588 (m), 1465 (m), 1456 (m), 1352 (s), 1287 (s), 1231 (s), 1191
(s), 1168 (s), 1136 (s), 1121 (s), 949 (s), 784 (s), 748 (s), 722 (m), 671 (s), 657
(m), 574 (s), 525 (m), 496 (s)
7.5. N,N’-ditosylhydrazine
7.5.1. Synthesis route and comments
N,N’-ditosylhydrazine was synthesized in 92 % yield in one step by the reaction
of tosylhydrazine with tosyl chloride in the presence of pyridine, as described
by Toma et al.,31a albeit with a slight modification of the work-up procedure.
The modified procedure requires less methanol than in the original procedure,
making the work-up easier and safer to perform on a preparative scale (∼ 100 g),
without compromising the purity of the isolated product.
The reaction has been performed once following the original procedure, with a
yield comparable to that reported. The procedure was originally performed on a
50 mmol scale and employed a recrystallization from 400 mL of boiling MeOH
as the final purification step. The yield was 15 g (85 %).
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In the modified work-up procedure, the crude precipitate (see experimental
details below) is simply slurried in methanol at reflux, lowering the expenditure
of MeOH considerably.
The reaction could thus be performed at various scales with a low methanol
expenditure:
Scale (mmol) MeOH volume (mL) Yield (g) Yield (%)
100 400 31 92
192 500 61 93
300 800 95 93
350 900 109 92
The 1H-NMR and13C-NMR spectra of the obtained products where identical to
those of the product obtained using the original procedure, and are in accordance
with the published spectroscopic data. An X-ray structure can also be found in
the literature.48
7.5.2. Experimental procedure
Tosyl chloride (100.0 g, 524.5 mmol, 1.5 eq) and tosylhydrazide (65.12 g, 349.7
mmol, 1.0 eq) were added to a 1000 mL round-bottom flask through a solid
addition funnel, and dissolved/suspended in anhydrous CH2Cl2 (250 mL),
giving a concentration of approximately 1 M based on the limiting reactant. An
oval stir bar (3.5 × 1.5 cm) was added and the suspension stirred (700 rpm) while
cooling on an ice/water bath, until an internal temperature of 3 °C was reached.
Addition of a solution of pyridine (41.49 g, 524.5 mmol, 1.5 eq) in anhydrous
CH2Cl2 (80 mL) over a period of 10 minutes, in such a way that the internal
temperature did not rise above 20 °C. This gave a transparent yellow solution
which soon deposited a white precipitate, upon which stirring was increased to
1000 rpm, and continued for a period of 3 hours.
Et2O (200 mL) was added and the suspension solidified. The heavy precipita-
tion was broken up with a spatula and the suspension was transferred to a 1500
mL beaker, where it was stirred with a triangular stir bar (5 × 1 × 1 cm). H2O
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(Type II, 200 mL) and Et2O (200 mL) was added in the given order. Stirring was
continued for 10 minutes, before filtering the precipitate on a 13 cm Büchner-
funnel, where it was left to air dry with suction for a period of 5 minutes.
The solid was transferred directly to a 2000 mL round bottom flask and
suspended in MeOH (900 mL). The flask was equipped with a reflux-condenser
and an oval stir bar (5 × 2 cm) before heating the suspension to reflux (mantle
temperature 67 °C) and stirring for a period of 3 hours. The suspension, which
at this point would separate to slightly yellow solution above a bright white
precipitate, was allowed to cool before filtering on a 13 cm Büchner-funnel. The
filter cake was washed with MeOH (300 mL) and Et2O (300 mL). The filtrate was
then concentrated on a rotary evaporator (bath temperature∼ 45 °C) to a volume
of approximately 150 mL, before cooling the flask under running tap water. The
precipitate was filtered on a Büchner-funnel, washed with MeOH (200 mL) and
Et2O (200 mL) giving a second crop. The first crop was a voluminous white
powder, while the second more crystalline crop consists of short white needles.
Both crops where dried in air in a fume hood over a period of 48 hours before
determining the yield. Crop I: 97.60 g (81 %), crop II: 12.34 g (10 %). The total
yield was 109.94 g (92 %). Both crops were of equal purity by NMR analysis
and were subsequently mixed and stored in a screw-capped PTFE jar at ambient
temperature.
7.5.3. Physical data
• 1H-NMR (300 MHz, DMSO−d6) δ 2.40 (s, 6H), 7.37 – 7.40 (m, 4H), 7.64 –
7.67 (m, 4H), 9.59 (s, 2H)
• 13C-NMR (75 MHz, DMSO−d6) δ 21.0, 127.8, 129.4, 135.5, 143.4
• Melting point: 212 – 215 °C (decomposition)
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8. α-bromoacetamides
8.0.4. Synthesis route and comments
The α-bromoacetamides were synthesized by the slow addition of the amine
in CH2Cl2 (20 mmol/30 mL) to bromoacetyl bromide and tribasic potassium
phosphate in CH2Cl2. The procedure was based on a recent publication where the
authors have optimized the formation of amides from amines and acid chlorides
with respect to the base.31c
8.1. 2-bromo-1-(pyrrolidin-1-yl)ethanone (1b)
8.1.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (6.061 g, 30.02 mmol, 1.5 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(10.63 g, 50.05 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added and the
flask was fitted with a 100 mL addition funnel, containing pyrrolidine (1.423 g,
20.01 mmol, 1 eq) in anhydrous CH2Cl2 (30 mL). The flask was cooled on an
ice/water bath, while purging the system with argon, for a period of 5 minutes.
Stirring (500 rpm) was commenced and the amine solution added drop wise
over a period of 30 minutes, after which the addition funnel was washed with
anhydrous CH2Cl2 (5 mL). Stirring was then continued for a period of 165
minutes, before quenching the excess acid bromide with aqueous HCl (0.5 M,
30 mL). After stirring another 5 minutes, H2O (10 mL) and brine (10 mL) were
added and the now transparent two phases transferred to a separatory funnel
and the organic phase drained off. The aqueous phase was extracted with CH2Cl2
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(1 × 20 mL), before washing the joint organic phases with a mixture of aqueous
KHCO3 (10 %wt, 20 mL) and brine (10 mL), and then with brine (20 mL). Drying
over MgSO4 and evaporating under reduced pressure at 30 °C bath temperature,
afforded 3.466 g (90 %) of a slightly brown oil which crystallized upon cooling
to ambient temperature. The crude material was stored at −20 °C for period of
approximately 70 days before being submitted to the next synthetic step.
8.1.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.77 (s, 2H), 3.51 – 3.42 (m, 4H), 2.03 – 1.80
(m, 4H)
• 13C-NMR (75 MHz, CDCl3) δ 164.9, 46.9, 46.3, 27.3, 26.0, 24.2
• MS (EI) m/z (% rel. int.) 193/191 (M+, 16/16), 121/123 (4/4), 112 (100), 98
(81), 93/95 (6/6), 70 (48)
• HRMS (EI) Calcd. for C6H10
79BrNO [M+]: 190.9946; found 190.9950 (−2.2
ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.35
8.2. 2-bromo-1-(piperidin-1-yl)ethanone (2b)
8.2.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (12.162 g, 60.25 mmol, 1.5 eq), anhydrous CH2Cl2 (40 mL) and K3PO4
(21.248 g, 100.09 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added and
the flask was fitted with a 100 mL addition funnel, containing piperidine (3.407
g, 40.01 mmol, 1 eq) in anhydrous CH2Cl2 (60 mL). The flask was cooled on an
ice/water bath, while purging the system with argon, for a period of 5 minutes.
Stirring (500 rpm) was commenced and the amine solution added drop wise
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over a period of 2.5 hours, after which the addition funnel was washed with
anhydrous CH2Cl2 (5 mL). Stirring was then continued for a period of 4 hours,
before quenching the excess acid bromide with aqueous HCl (0.5 M, 60 mL). After
stirring another 5 minutes, the now transparent two phases were transferred to
a separatory funnel and the organic phase drained off. The aqueous phase was
extracted with CH2Cl2 (1 × 20 mL), before washing the joint organic phases with
a mixture of aqueous KHCO3 (10 %wt, 50 mL) and brine (20 mL). The aqueous
phase was back-extracted with CH2Cl2 (1 × 20 mL) and the joint organic phases
were washed with brine (40 mL). Drying over MgSO4 and evaporating under
reduced pressure at or below ambient temperature, afforded 7.750 g (94 %) of a
slightly yellow oil. The crude material solidified to a peach crystalline solid upon
storage at −20 °C.
8.2.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.84 (s, 2H), 3.57 – 3.49 (m, 2H), 3.46 – 3.36
(m, 2H), 1.69 – 1.59 (m, 4H), 1.59 – 1.48 (m, 2H)
• 13C-NMR (75 MHz, CDCl3) δ 165.0, 47.8, 43.2, 26.1, 26.1, 25.3, 24.2
• MS (EI) m/z (% rel. int.) 207/205 (M+, 4/4), 126 (100), 123/121 (3/4), 112
(20), 95/93 (2/2), 84 (18)
• MS (ESI, Q-TOF) (MeOH) m/z 230.0/228.0 [M+Na]+, 208.0/206.0 [M+H]+
• HRMS (EI) Calcd. for C7H12
79BrNO) [M+]: 205.0102; found 205.0104 (−1.0
ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.54
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8.3. 1-(azepan-1-yl)-2-bromoethanone (3b)
8.3.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (6.064 g, 30.04 mmol, 1.5 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(10.621 g, 50.03 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added
and the flask was fitted with a 100 mL addition funnel, containing azepane
(hexamethyleneimine) (1.985 g, 20.01 mmol, 1 eq) in anhydrous CH2Cl2 (30 mL).
The flask was cooled on an ice/water bath, while purging the system with argon,
for a period of 5 minutes. Stirring (500 rpm) was commenced and the amine
solution added drop wise over a period of 60 minutes, after which the addition
funnel was washed with anhydrous CH2Cl2 (5 mL). Stirring was then continued
for a period of 3.5 hours, before quenching the excess acid bromide with aqueous
HCl (0.5 M, 30 mL). After stirring another 5 minutes, H2O (10 mL) and brine (10
mL) were added and the now transparent two phases transferred to a separatory
funnel and the organic phase drained off. The aqueous phase was extracted with
CH2Cl2 (1 × 20 mL), before washing the joint organic phases with a mixture of
aqueous KHCO3 (10 %wt, 30 mL) and brine (10 mL), and then with brine (20 mL).
Drying over MgSO4 and evaporating under reduced pressure at 25 °C, afforded
4.151 g (94 %) of a transparent oil. The crude material was stored at −20 °C
for period of approximately 30 days before being submitted to the following
synthetic step.
8.3.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.84 (s, 2H), 3.54 – 3.42 (m, 4H), 1.82 – 1.62
(m, 4H), 1.62 – 1.47 (m, 4H)
• 13C-NMR (75 MHz, CDCl3) δ 166.3, 48.5, 46.3, 28.9, 27.2, 27.1, 26.4, 26.4
• MS (EI) m/z (% rel. int.) 221/219 (M+, 1/1), 140 (100), 126 (7), 123/121 (2/3),
98(8), 95/93 (2/2)
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• HRMS (EI) Calcd. for C8H14
79BrNO) [M+]: 219.0259; found 219.0257 (0.6
ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.45
8.4. tert-butyl 4-(2-bromoacetyl)piperazine-1-carboxylate
(4b)
8.4.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (6.099 g, 30.21 mmol, 1.5 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(10.632 g, 50.08 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added and the
flask was fitted with a 100 mL addition funnel, containing tert-butyl piperazine-
1-carboxylate (3.725 g, 20.00 mmol, 1 eq) in anhydrous CH2Cl2 (30 mL). The flask
was cooled on an ice/water bath, while purging the system with argon, for a
period of 5 minutes. Stirring (500 rpm) was commenced and the amine solution
added drop wise over a period of 30 minutes, after which the addition funnel
was washed with anhydrous CH2Cl2 (5 mL). Stirring was then continued for
a period of 2 hours, before quenching the excess acid bromide with aqueous
HCl (0.5 M, 30 mL). After stirring another 5 minutes, H2O (10 mL) and brine (10
mL) were added and the now transparent two phases transferred to a separatory
funnel and the organic phase drained off. The aqueous phase was extracted with
CH2Cl2 (1 × 20 mL), before washing the joint organic phases with a mixture
of aqueous KHCO3 (10 %wt, 20 mL) and brine (10 mL), and then with brine
(20 mL). Drying over MgSO4 and evaporating under reduced pressure at or
below ambient temperature, left an oil which upon addition of Et2O (10 mL) and
reevaporation, afforded 5.885 g (95 %) of a white solid. The crude material was
stored at −20 °C for period of approximately 70 days before being submitted to
the following synthetic step.
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8.4.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.85 (s, 2H), 3.62 – 3.38 (m, 8H), 1.45 (s, 9H)
• 13C-NMR (75 MHz, CDCl3) δ 165.4, 154.4, 80.4, 46.5 (2C), 41.9 (2C), 28.3
(3C), 25.6
• MS (EI) m/z (% rel. int.) 308/306 (M+, 4/4), 252/250 (9/9), 235/233 (9/9),
207/205 (2/1), 171 (22), 170 (37), 127 (16), 123/121 (3/3), 113 (14), 95/93
(1/2), ( 85 (35), 57 (100)
• HRMS (EI) Calcd. for C11H19
79BrN2O3) [M
+]: 306.0579; found 306.0587
(−2.7 ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.14
8.5. N,N’-bis(2-bromoacetyl)piperazine (5b)
8.5.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (6.088 g, 30.16 mmol, 3 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(10.649 g, 50.16 mmol, 5 eq). An oval stir bar (3.5 × 1.5 cm) was added and
the flask was fitted with a 100 mL addition funnel, containing piperazine (0.865
g, 10.05 mmol, 1 eq) in anhydrous CH2Cl2 (40 mL). The flask was cooled on
an ice/water bath, while purging the system with argon, for a period of 5
minutes. Stirring (500 rpm) was commenced and the amine solution added drop
wise over a period of 2.5 hours, after which the addition funnel was washed
with anhydrous CH2Cl2 (3 × 5 mL). Stirring was then continued for a period
of 5 hours, before quenching the excess acid bromide with aqueous HCl (0.5
M, 30 mL). After stirring another 5 minutes, H2O (10 mL) and brine (10 mL)
were added and the now transparent two phases transferred to a separatory
funnel and the organic phase drained off. The aqueous phase was extracted with
CH2Cl2 (1 × 20 mL), before washing the joint organic phases with a mixture of
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aqueous KHCO3 (10 %wt, 30 mL) and brine (10 mL), and then with brine (20
mL). Drying over MgSO4 and evaporating under reduced pressure at or below
ambient temperature afforded 2.746 g (83 %) of a white solid. The crude material
was stored at−20 °C for period of approximately 15 days before being submitted
to the following synthetic step.
8.5.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.88 (s, 4H), 3.78 – 3.46 (m, 8H)
• 13C-NMR (75 MHz, CDCl3) δ 165.6 (2C), 46.3, 46.1, 41.8, 41.6, 25.3 (2C)
• MS (EI) m/z (% rel. int.) 330/328/326 (M+, 2/4/2), 249/247 (39/40), 248/246
(35/33), 235/233 (12/12), 207/205 (20/21), 168 (8), 127 (7), 123/121 (11/11),
113 (11), 95/93 (8/8), 85 (100)
• HRMS (EI) Calcd. for C8H12Br
79
2 N2O2) [M
+]: 325.9266; found 325.9256 (3.1
ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.20
8.6. 2-bromo-1-morpholinoethanone (6b)
8.6.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (6.181 g, 30.62 mmol, 1.5 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(10.625 g, 50.05 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added and
the flask was fitted with a 100 mL addition funnel, containing morpholine
(1.7423 g, 20.00 mmol, 1 eq) in anhydrous CH2Cl2 (30 mL). The flask was cooled
on an ice/water bath, while purging the system with argon, for a period of
5 minutes. Stirring (500 rpm) was commenced and the amine solution added
drop wise over a period of 30 minutes, after which the addition funnel was
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washed with anhydrous CH2Cl2 (5 mL). Stirring was then continued for a period
of 2 hours, before quenching the excess acid bromide with aqueous HCl (0.5
M, 30 mL). After stirring another 5 minutes, H2O (10 mL) and brine (10 mL)
were added and the now transparent two phases transferred to a separatory
funnel and the organic phase drained off. The aqueous phase was extracted with
CH2Cl2 (1 × 20 mL), before washing the joint organic phases with a mixture
of aqueous KHCO3 (10 %wt, 20 mL) and brine (10 mL), and then with brine
(20 mL). Drying over MgSO4 and evaporating under reduced pressure at or
below ambient temperature afforded 3.737 g (89 %) of a slightly brown oil which
solidified upon refrigeration. The crude material was stored at −20 °C for period
of approximately 60 days before being submitted to the following synthetic step.
8.6.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 3.83 (s, 2H), 3.75 – 3.64 (m, 4H), 3.64 – 3.56
(m, 2H), 3.54 – 3.47 (m, 2H)
• 13C-NMR (75 MHz, CDCl3) δ 165.3, 66.5, 66.3, 47.1, 42.3, 25.4
• MS (EI) m/z (% rel. int.) 209/207 (M+, 21/21), 194/192 (14/15), 128 (100),
123/121 (14/14), 114 (16), 95/93 (5/5), 86 (79)
• HRMS (EI) Calcd. for C6H10
79BrNO2) [M
+]: 206.9895; found 206.9888 (3.5
ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.37
8.7. 2-bromo-1-thiomorpholinoethanone (7b)
Upon evaporation of the dichloromethane used for extraction, the became an
insoluble lacquer, possibly caused by an intermolecular reaction between the
thioether and the α-bromo amide to form a salt (it slowly dissolved in HCl (aq,
0.5 M))
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8.7.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (6.105 g, 30.24 mmol, 1.5 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(10.625 g, 50.05 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added and
the flask was fitted with a 100 mL addition funnel, containing thiomorpholine
(2.068 g, 20.04 mmol, 1 eq) in anhydrous CH2Cl2 (30 mL). The flask was cooled
on an ice/water bath, while purging the system with argon, for a period of 5
minutes. Stirring (500 rpm) was commenced and the amine solution added drop
wise over a period of 30 minutes, after which the addition funnel was washed
with anhydrous CH2Cl2 (5 mL). Stirring was then continued for a period of 100
minutes, before quenching the excess acid bromide with aqueous HCl (0.5 M,
30 mL). After stirring another 5 minutes, H2O (10 mL) and brine (10 mL) were
added and the now transparent two phases transferred to a separatory funnel.
The aqueous phase was discarded and the organic phase washed with a mixture
of aqueous KHCO3 (10 %wt, 30 mL) and brine (10 mL), and then with brine (20
mL). Drying over MgSO4 and evaporating under reduced pressure at 30 °C left
4.375 g (97 %) of a brittle golden solid. This solid would not dissolve in CH2Cl2,
CHCl3, MeOH, MeCN, Et2O or THF, however it slowly dissolved in DMSO and
HCl (aq, 0.5 M). Further synthesis with this compound was not attempted.
8.8. 2-bromo-1-(1,1-dioxidothiomorpholino)ethanone
(8b)
The solubility of both the amine thiomorpholine-1,1-dioxide and the obtained
amide is relatively poor in CH2Cl2. As such, the CH2Cl2 volume in which the
amide was initially dissolved was increased in relationship to the other analogues
(7 mmol/30 mL), as well as the extraction volume (150 mL). A longer reaction
time was also needed to reach full conversion.
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8.8.1. Experimental procedure
A 250 mL round bottom flask was charged, in the given order, with bromoacetyl
bromide (2.309 g, 11.44 mmol, 1.5 eq), anhydrous CH2Cl2 (20 mL) and K3PO4
(3.934 g, 18.53 mmol, 2.5 eq). An oval stir bar (3.5 × 1.5 cm) was added and
the flask was fitted with a 100 mL addition funnel, containing thiomorpholine-
1,1-dioxide (1.001 g, 7.40 mmol, 1 eq) in anhydrous CH2Cl2 (30 mL). The flask
was cooled on an ice/water bath, while purging the system with argon, for a
period of 5 minutes. Stirring (500 rpm) was commenced and the amine solution
added drop wise over a period of 1 hour, after which the addition funnel was
washed with anhydrous CH2Cl2 (5 mL). Stirring was then continued for a period
of 23 hours, before quenching the excess acid bromide with aqueous HCl (0.5 M,
30 mL). After stirring another 5 minutes, the mixture was diluted with CH2Cl2
(100 mL) to give two transparent phases which were transferred to a separatory
funnel. The aqueous phase was discarded and the organic phase washed with a
mixture of aqueous KHCO3 (10 %wt, 20 mL) and brine (10 mL), and then with
brine (20 mL). Drying over MgSO4 and evaporating under reduced pressure at or
below ambient temperature, afforded 1.7328 g (91 %) of a white crystalline solid.
The crude material was stored at −20 °C for period of approximately 50 days
before being submitted to the following synthetic step.
8.8.2. Physical data
• 1H-NMR (300 MHz, CD3CN) δ 4.06 (s, 2H), 4.01 – 3.86 (m, 4H), 3.20 – 2.96
(m, 4H)
• 13C-NMR (75 MHz, CD3CN) δ 163.2, 52.3, 52.1, 45.7, 41.6, 27.8
• MS (EI) m/z (% rel. int.) 257/255 (M+, 1/1), 193/191 (1/1), 192/190 (2/2),
176 (41), 162 (9), 134 (45), 123/121 (14/14), 112 (100), 95/93 (8/9), 70 (44)
• HRMS (EI) Calcd. for C6H10
79BrNO3S) [M
+]: 254.9565; found 254.9565
(−0.2 ppm)
• TLC (Al2O3 (N), 1 × CH2Cl2) R f : 0.29
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9. α-diazoacetamides
9.0.3. Synthesis route and comments
The α-diazoacetamides were synthesized by the procedure of Toma et al.,31a
modified as described in section 3.3 on page 33.
The solvent-dependent fragments observed in the mass spectrometry experi-
ments (ESI) have (possibly) been noted by others.49
9.1. 2-diazo-1-(pyrrolidin-1-yl)ethanone (1c)
The compound was obtained as a
yellow oil at ambient temperature
which solidified to a crystalline solid
at −20 °C. Upon exposure to am-
bient temperature the solid melts
within minutes. The yield was 67 %
starting from 2-bromo-1-(pyrrolidin-
1-yl)ethanone and 61 % starting from
pyrrolidine.
The compound is previously re-
ported in the literature.37b,37i
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9.1.1. Experimental procedure
To a 250 mL round bottom flask containing 2-bromo-1-(pyrrolidin-1-yl)ethanone
(3.466 g, 18.05 mmol, 1 eq), were added through a solid addition funnel N,N’-
ditosylhydrazine (12.290 g, 36.10 mmol, 2 eq), THF (35 mL) and an oval stir
bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath with
stirring (400 rpm) for a period of 5 minutes, upon which a solution of 1,1,3,3-
tetramethylguanidine (8.319 g, 72.23 mmol, 4 eq) in THF (5 mL) was added in
aliquots using a pasteur pipette over a period of 2 minutes. During the addition
the white suspension became yellow and at one point almost transparent, before
depositing a white precipitate in a bright yellow solution. This suspension was
stirred for a period of 60 minutes, before removing the THF under reduced
pressure at or below ambient temperature. The resulting solid was treated with
anhydrous Et2O (150 mL) and vigorously stirred for 10 minutes, before being
filtered on a Büchner-funnel. The filter cake was washed with anhydrous Et2O
(2 × 50 mL), leaving an almost white filter cake. The bright yellow filtrate was
filtered again through a folded filter into a 500 mL round bottom flask. The Et2O
was then evaporated under reduced pressure at or below ambient temperature,
to give 2.5632 g of yellow oil.
By 1H-NMR, the oil chiefly consists of the desired product (∼ 85 %wt)
and the α-tosyl amide (∼ 15 %wt), thus amounting to a crude yield of ∼ 87
%. The oil was dissolved in Et2O/Pet.Ether (1:1, 10 mL) and loaded onto a
column (8.0 × 3.5 cm) of silica gel packed in Et2O/Pet.Ether (1:1). Elution of one
broad yellow band with Et2O/Pet.Ether (1:1) afforded, after evaporation of the
eluent, a bright yellow oil. The solvent expenditure was ∼ 1.4 L. A 1H-NMR
showed that the separation of diazoacetamide from the α-tosyl amide was fairly
successful, however other tosyl species, plausibly p-toluene sulfinic acid or p-
toluene sulfonic acid, had eluted together with the product.
The oil was dissolved in Et2O (100 mL), transferred to a separatory funnel
and washed with a 5 %wt NaOH solution saturated with NaCl (4 × 25 mL), and
then with brine (1 × 20 mL). The joint aqueous phases were placed in a beaker
and saturated by adding NaCl in excess. This suspension was back-extracted by
stirring vigorously with Et2O (3 × 20 mL) and decanting the top phase into a
separatory funnel, were the phases were separated. The joint organic phases were
evaporated under reduced pressure, dissolved in CH2Cl2 and dried over Na2SO4.
Filtration and evaporation of the solvent under reduced pressure, afforded 1.706
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g (67 %) of a bright yellow oil.
9.1.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 4.92 (s, 1H), 3.54 – 2.98 (m, 4H), 2.06 – 1.64
(m, 4H)
• 13C-NMR (75 MHz, CD2Cl2) δ 163.8, 46.4, 46.2 (2C), 26.1, 24.8
• MS (ESI, FT-ICR) (MeCN, no HCOOH) m/z 162.0 [M + Na]+
• TLC (SiO2, 1 × Et2O) R f : 0.13
• TLC (SiO2, 3 × Et2O) R f : 0.30
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9.2. 2-diazo-1-(piperidin-1-yl)ethanone (2c)
The compound was obtained as a
yellow oil at ambient temperature
which solidified to a crystalline solid
at −20 °C. Upon exposure to ambient
temperature the solid melts over some
ten minutes. The yield was 52 %
starting from 2-bromo-1-(piperidin-1-
yl)ethanone and 49 % starting from
piperidine.
The compound is previously
reported in several publications.27b,37h,32a,33b,37c,37d,37e,37f
9.2.1. Experimental procedure
To a 250 mL round bottom flask containing 2-bromo-1-(piperidin-1-yl)ethanone
(7.750 g, 37.61 mmol, 1 eq), were added through a solid addition funnel N,N’-
ditosylhydrazine (25.619 g, 75.26 mmol, 2 eq), THF (85 mL) and an oval stir
bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath with
stirring (400 rpm) for a period of 10 minutes, upon which a solution of 1,1,3,3-
tetramethylguanidine (21.668 g, 188.12 mmol, 5 eq) in THF (20 mL) was added in
aliquots using a pasteur pipette over a period of 5 minutes. During the addition
the white suspension became yellow and at one point almost transparent, before
depositing a white precipitate in a bright yellow solution. This suspension was
stirred for a period of 90 minutes, before removing the THF under reduced
pressure at or below ambient temperature. The resulting solid was treated with
anhydrous Et2O (150 mL) and vigorously stirred for 10 minutes, before being
filtered on a Büchner-funnel. The filter cake was washed with anhydrous Et2O
(2 × 50 mL), leaving an almost white filter cake. The bright yellow filtrate was
transferred to a separatory funnel and washed with a 5 %wt NaOH solution
saturated with NaCl (3 × 50 mL). During washing, the aqueous phases had
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become turbid and yellow, thus they were combined, brine (20 mL) was added
and they were back-extracted with CH2Cl2 (3 × 30 mL). The CH2Cl2 was
evaporated under reduced pressure and the residue extracted with Et2O (2 × 30
mL), before combining the ethereal phases and drying over Na2SO4. Evaporation
under reduced pressure at or below ambient temperature left 5.4 g of yellow oil
(∼ 90 % of theoretical maximum weight)
The oil was redissolved in Et2O (50 mL) and TLC-grade silica gel (5
tablespoons) were added, before evaporating the Et2O, leaving a yellow powder.
This powder was placed over a column of alumina (B, 20 cm × 3 cm) packed
in CH2Cl2 and then equilibrated with petroleum ether. Elution with petroleum
ether (100 mL), Et2O/Pet.Ether (1:1, 400 mL) and then Et2O (600 mL) separated
a yellow band. During elution, bubbling from within the column was observed
possibly indicating some decomposition of the diazoacetamide on alumina (B).
The total solvent expenditure was 1.1 L. The yield was 3.008 g (52 %)
9.2.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 5.16 (s, 1H), 3.30 (bs, 4H), 1.66 – 1.55 (m, 2H),
1.55 – 1.42 (m, 4H)
• 13C-NMR (75 MHz, CD2Cl2) δ 164.3, 46.1, 45.2 (2C), 26.2, 24.8 (2C)
• MS (EI) m/z (% rel. int.) 154 (5), 153 (M+, 25), 125 (19), 112 (11), 96 (45), 84
(38), 69 (53), 55 (71), 42 (100), 41 (79)
• MS (ESI, Q-TOF) (MeCN) m/z 167.1 [M + H−N2 + MeCN]+
• MS (ESI, Q-TOF) (MeOH) m/z 180.1 [M + Na−N2 + MeOH]+, 158.1 [M +
H−N2 + MeOH]+
• MS (ESI, FT-ICR) (MeCN, no HCOOH) m/z 176.1 [M + Na]+
• HRMS (EI) Calcd. for C7H11N3O) [M
+]: 153.0902; found 153.0891 (7.2 ppm)
• TLC (SiO2, 1 × Et2O) R f : 0.28
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1-(piperidin-1-yl)-2-tosylethanone –– a commonly observed by-product:31a
• MS (EI) m/z (% rel. int.) 282 (M++1, 1), 217 (26), 155 (6), 127 (14), 126 (100),
112 (42), 110 (30), 97 (29), 91 (43), 84 (34)
• MS (ESI, Q-TOF) (MeCN) m/z 282.2 [M + H]+, 585.3 [2 M + Na]+
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9.3. 1-(azepan-1-yl)-2-diazoethanone (3c)
The compound was obtained as a soft
yellow solid at ambient temperature. The
yield was 66 % starting from 1-(azepan-1-
yl)-2-bromoethanone and 63 % starting from
azepane.
The compound is previously reported as a
reagent,37h however no details on its synthesis
were disclosed.
9.3.1. Experimental procedure
To a 250 mL round bottom flask containing 1-(azepan-1-yl)-2-bromoethanone
(4.151 g, 18.86 mmol, 1 eq), were added through a solid addition funnel N,N’-
ditosylhydrazine (12.842 g, 37.72 mmol, 2 eq), THF (45 mL) and an oval
stir bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath
with stirring (400 rpm) for a period of 8 minutes, upon which a solution of
1,1,3,3-tetramethylguanidine (10.864 g, 94.32 mmol, 5 eq) in THF (30 mL) was
added using a pasteur pipette over a period of 6 minutes. At this point the
bath temperature was 3 °C and the internal temperature was 12 °C. During
the addition the white suspension became yellow and at one point almost
transparent, before depositing a white precipitate in a bright yellow solution.
This suspension was stirred for a period of 60 minutes, before removing the
THF under reduced pressure at or below ambient temperature. The resulting
solid was treated with anhydrous Et2O (100 mL) and vigorously stirred for 10
minutes, before being filtered on a Büchner-funnel. The filter cake was washed
with anhydrous Et2O (3 × 50 mL), leaving an almost white filter cake. The bright
yellow filtrate was filtered again through a folded filter into a 500 mL round
bottom flask. The solution was then concentrated under reduced pressure to ∼
10 mL and loaded onto a column (8.5 × 3.5 cm) of silica gel packed in Et2O.
Elution of a yellow band with Et2O left, upon evaporation of the solvent, 2.634
g (75 %) of a bright yellow waxy solid with an irritating smell. By 1H-NMR the
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solid chiefly consists of the product (∼ 90 %wt) and the α-tosyl amide (∼ 10
%wt). The solid was rechromatographed on a column (7.0 × 3.5 cm) of silica gel
packed in Et2O/Pet.Ether (25:75). The compound was eluted isocratically with
Et2O/Pet.Ether (25:75), yielding 2.217 g (66 %) of a bright yellow solid, which
was stored at −20 °C.
9.3.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 5.07 (s, 1H), 3.68 – 3.00 (m, 4H), 1.79 – 1.61
(m, 4H), 1.61 – 1.43 (m, 4H)
• 13C-NMR (75 MHz, CD2Cl2) δ 165.2, 47.8, 46.2 (2C), 28.8 (2C), 27.5, 27.3
• MS (EI) m/z (% rel. int.) 168 (7), 167 (M+, 16), 139 (7), 138 (15), 126 (8), 111
(9), 110 (21), 96 (61), 69 (64), 55 (65), 41 (100)
• MS (ESI, FT-ICR) (MeCN, no HCOOH) m/z 190.1 [M + Na]+
• HRMS (EI) Calcd. for C8H13N3O [M
+]: 167.1059; found 167.1060 (−0.6 ppm)
• TLC (SiO2, 1 × Et2O) R f : 0.39
• TLC (SiO2, 5 × Et2O/Pet.Ether (1:1)) R f : 0.45
• Melting point: 48 – 50 °C
Dimerization was observed in the mass spectrometer (EI) as has been noted by others.50
The dimer radical cation had the following characteristics:
• MS (EI) m/z (% rel. int.) 279 (5), 278 (M+, 4), 181 (12), 180 (12), 152 (8), 149
(17), 110 (13), 98 (100)
• HRMS (EI) Calcd. for C16H26N2O2 [M
+]: 278.1994; found 278.1984 (3.8 ppm)
1-(azepan-1-yl)-2-tosylethanone –– a commonly observed by-product: 31a
• TLC (SiO2, 5 × Et2O/Pet.Ether (1:1)) R f : 0.17
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9.4. tert-butyl 4-(2-diazoacetyl)piperazine-1-carboxylate
(4c)
The compound was obtained
as a yellow amorphous solid
at ambient temperature. The
yield was 60 % starting from
tert-butyl 4-(2-bromoacetyl)-
piperazine-1-carboxylate and
56 % starting from N-Boc-
piperazine.
The compound is previously unreported.15
9.4.1. Experimental procedure
To a 250 mL round bottom flask containing tert-butyl 4-(2-bromoacetyl)piperazine-
1-carboxylate (5.885 g, 19.16 mmol, 1 eq) were added, through a solid addition
funnel, N,N’-ditosylhydrazine (13.045 g, 38.32 mmol, 2 eq), THF (40 mL) and an
oval stir bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath with
stirring (400 rpm) for a period of 10 minutes, upon which a solution of 1,1,3,3-
tetramethylguanidine (11.043 g, 95.88 mmol, 5 eq) in THF (20 mL) was added
using a pasteur pipette over a period of 2 minutes. During the addition the white
suspension became yellow and at one point almost transparent, before depositing
a white precipitate in a bright yellow solution. This suspension was stirred for a
period of 70 minutes, before removing the THF under reduced pressure at or
below ambient temperature.
The resulting solid was treated with anhydrous Et2O (200 mL) and vigorously
stirred for 10 minutes, before being filtered on a Büchner-funnel. The filter cake
was washed with anhydrous Et2O (5 × 50 mL), leaving an almost white filter
cake. The bright yellow filtrate was filtered again through a folded filter into a 500
mL round bottom flask. The Et2O was then evaporated under reduced pressure
at or below ambient temperature to give a bright yellow solid. This solid was
dissolved in Et2O/CH2Cl2 (1:1, 10 mL) and loaded onto a column (10.0 × 3.5
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cm) of silica gel and eluted with Et2O/CH2Cl2 (1:1, 450 mL). TLC- and NMR-
analyses of the eluted band show that a clean separation of the product and the
α-tosyl amide had not been achieved.
Thus to the combined fractions was added silica gel (3 tablespoons), and the
solvents evaporated under reduced pressure. The resulting yellow powder was
placed on top of a column (10.0 × 3.5 cm) of silica gel packed in Et2O/Pet.Ether
(1:1). Elution with Et2O/Pet.Ether (1:1, 400 mL), Et2O/Pet.Ether (3:2, 500 mL) and
then Et2O/Pet.Ether (3:1, 350 mL) afforded 2.938 g (60 %) of a bright yellow solid,
which could be broken up to fine yellow powder with a spatula. The solvent
expenditure was 1.25 L.
XRD crystal growth
A 2.5 ml vial containing tert-butyl 4-(2-diazoacetyl)piperazine-1-carboxylate (10.8
mg) and dichloromethane (1000 µL) was capped and a pinhole (0.5 mm) was
made in the cap to allow for vapour diffusion of solvents. This vial was placed
inside a 25 ml vial containing n-pentane (8 ml) that was subsequently capped and
stored in the dark at ambient temperature for approximately 48 hours, affording
bright yellow plate-shaped crystals.
The first dataset recorded at ambient temperature and showed severe
distortion of the ring carbon electron densities. When a new dataset was recorded
at 105 K, the ring was in a well defined chair conformation. The structure was
recently published.51
9.4.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 5.13 (s, 1H), 3.47 – 3.21 (m, 8H), 1.42 (s, 9H)
• 13C-NMR (75 MHz, CD2Cl2) δ 165.0, 154.6, 80.1, 46.5, 43.9 (br, 4C), 28.4
• MS (EI) m/z (% rel. int.) 255 (1), 254 (M+, 10), 198 (11), 181 (6), 170 (64), 128
(8), 125 (6), 97 (10), 85 (31), 69 (20), 57 (100), 41 (32)
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• MS (ESI, Q-TOF) (MeCN) m/z 308.2 [M−N2 + 2 MeCN]+, 268.2 [M +
H−N2 + MeCN]+, 212.1 [M + H−N2−56 (iso−butene) + MeCN]+
• MS (ESI, Q-TOF) (MeOH) m/z 539.3 [2 M + Na−2 N2 + 2 MeOH]+, 281.1
[M + Na−N2 + MeOH]+, 203.1 [M + H−N2−56 (iso−butene) + MeOH]+
• MS (ESI, Q-TOF) (MeCN, no HCOOH) m/z 277.1 [M + Na]+
• HRMS (EI) Calcd. for C11H18N4O3) [M
+]: 253.1379; found 254.1374 (2.1
ppm)
• TLC (SiO2, 1 × Et2O) R f : 0.20
• Melting point: 108 – 111 °C
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9.5. N,N’-bis(2-diazoacetyl)piperazine (5c)
The compound was obtained
as a yellow amorphous solid
at ambient temperature. The
yield was 58 % starting from
N,N’-bis(2-bromoacetyl) piper-
azine and 48 % starting from
piperazine.
The compound is generally poorly soluble in common solvents, and is
previously unreported.15
9.5.1. Experimental procedure
To a 250 mL round bottom flask containing N,N’-bis(2-bromoacetyl)piperazine
(2.746 g, 8.37 mmol, 1 eq) were added, through a solid addition funnel, N,N’-
ditosylhydrazine (11.401 g, 33.49 mmol, 4 eq), THF (50 mL) and an oval stir
bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath with
stirring (400 rpm) for a period of 10 minutes, upon which a solution of 1,1,3,3-
tetramethylguanidine (9.650 g, 83.78 mmol, 10 eq) in THF (10 mL) was added in
bulk. After the addition the white suspension slowly became yellow and a white
precipitate was deposited in a dark yellow solution. This suspension was stirred
for a period of 60 minutes, before removing the THF under reduced pressure at
or below ambient temperature.
The resulting solid was treated with anhydrous Et2O (100 mL) and then THF
(100 mL) as it would not dissolve/suspend in only Et2O. The mixture was
vigorously stirred for 10 minutes, before being filtered on a Büchner-funnel.
The filter cake was washed with THF/Et2O (1:1, 100 mL) and then THF (2 ×
50 mL). The filtrate was set aside and the filter cake washed with MeCN (2
× 100 mL) as it was not completely decolourized by the THF. The addition of
MeCN caused a noticeable colour change, and a dark yellow filtrate and an
almost white filter cake resulted. TLC-analyses indicated that the product was
present in both filtrates, and they were thus combined. Addition of silica gel (4
90
N,N’-bis(2-diazoacetyl)piperazine (5c)
tablespoons) and subsequent evaporation of the solvents under reduced pressure
at 20 °C, gave a light yellow powder. The powder was placed on top of a column
(9.0 × 3.5 cm) of silica gel packed in THF/CH2Cl2/Et2O (1:1:2) and eluted with
THF/CH2Cl2/Et2O (1:1:2, 600 mL) and then THF/CH2Cl2/Et2O (1:1:1, 600 mL)
affording a light yellow fraction. A TLC-analysis showed the presence of the
same contamination in all the fractions, possibly due to a low solubility of the
contaminant when Et2O was used in the eluent. The solvent expenditure was
1.2 L.
The fractions were combined and adsorbed on silica gel (3 tablespoons) by
evaporation of the solvents. The resulting powder was placed on top of a column
(10.0 × 3.5 cm) of silica gel packed in CH2Cl2 and eluted with THF/CH2Cl2 (5:95,
300 mL), THF/CH2Cl2 (6:94, 900 mL), until a pale yellow band started eluting,
and then with THF/CH2Cl2 (10:90, 100 mL), THF/CH2Cl2 (15:85, 400 mL) and
THF/CH2Cl2 (20:80, 600 mL). Solvent expenditure was 2.3 L. The combined
fractions were analysed by TLC and 1H-NMR, and found to be of acceptable
purity. The yield was 1.089 g (48 %).
XRD crystal growth
Crystals suitable for X-ray crystallography were grown by slow evaporation of
a solution of 4.0 mg of the compound in 500 µL of MeCN, placed in a vial
measuring 30 × 6 mm. After 48 hours in the dark at ambient temperature yellow
needles had grown. A crystal measuring 1.4 × 0.2 × 0.2 mm was selected and the
data were recorded at 105 K. The available crystallographic data are included in
the appendix.
9.5.2. Physical data
• 1H-NMR (300 MHz, CDCl3) δ 4.99 (s, 2H), 3.44 (bs, 8H)
• 13C-NMR (75 MHz, CDCl3) δ 165.0 (2C), 46.7 (2C), 43.4 (br, 4C)
• MS (EI) m/z (% rel. int.) 223 (1), 222 (M+, 7), 194 (1), 166 (28), 137 (6), 125 (8),
123 (39), 110 (9), 96 (21), 85 (64), 69 (100)
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• MS (ESI) (MeCN, no HCOOH) m/z 245.0 [M + Na]+
• HRMS (EI) Calcd. for C8H10N6O2) [M
+]: 222.0865; found 222.0865 (0.3 ppm)
• TLC (SiO2, 3 × THF/CH2Cl2 (2:8)) R f : 0.25
• Melting point: 109 °C (decomposition)
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9.6. 2-diazo-1-morpholinoethanone (6c)
The compound was obtained as a dark
yellow oil at ambient temperature,
which barely solidified at −20 °C. The
yield was 60 % starting from 2-bromo-
1-morpholinoethanone and 54 %
starting from morpholine.
The compound is previously
reported in several publications.32a,33b,37j
9.6.1. Experimental procedure
To a 250 mL round bottom flask containing 2-bromo-1-morpholinoethanone
(3.7369 g, 17.97 mmol, 1 eq), were added through a solid addition funnel N,N’-
ditosylhydrazine (12.333 g, 36.23 mmol, 2 eq), THF (40 mL) and an oval stir
bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath with
stirring (400 rpm) for a period of 5 minutes, upon which a solution of 1,1,3,3-
tetramethylguanidine (10.353 g, 30.41 mmol, 5 eq) in THF (30 mL) was added
using a pasteur pipette over a period of 4 minutes. During the addition the white
suspension became yellow and at one point almost transparent, before depositing
a white precipitate in a bright yellow solution. This suspension was stirred for a
period of 80 minutes, before removing the solvent under reduced pressure at
or below ambient temperature. The resulting solid was treated with anhydrous
Et2O (200 ml) and swirled before filtering on a Büchner-funnel. The filter cake
was washed with anhydrous Et2O (4 × 100 mL), leaving an almost white filter
cake. The bright yellow filtrate was evaporated under reduced pressure at or
below ambient temperature, during which time the residue became dark yellow,
then red and then dark brown. A TLC-analysis showed that the diazoacetamide
was still present.
The residue was shaken with Et2O (2 × 10 mL) and loaded onto a column (5.5
× 2.0 cm) of silica gel packed in Et2O. Elution with Et2O presented one yellow
band, leaving behind the dark tar at the top of the column. Evaporation under
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reduced pressure at or below ambient temperature, afforded 1.677 g (54 %) of
yellow oil. The oil was pure by TLC and by 1H-NMR, and solidified after three
days of storage at −20 °C.
9.6.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 5.05 (s, 1H), 3.68 – 3.56 (m, 4H), 3.37 – 3.23
(m, 4H)
• 13C-NMR (75 MHz, CD2Cl2) δ 165.1, 66.9 (2C), 46.3, 44.4 (2C)
• MS (EI) m/z (% rel. int.) 156 (10), 155 (M+, 74), 140 (13), 127(8), 114 (6), 98
(22), 86 (25), 69 (65), 56 (81), 41 (100)
• MS (ESI, FT-ICR) (MeCN, no HCOOH) m/z 178.0 [M + Na]+
• HRMS (EI) Calcd. for C6H9N3O2) [M
+]: 155.0695; found 155.0693 (1.1 ppm)
• TLC (SiO2, 1 × Et2O) R f : 0.15
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9.7. 2-diazo-1-(1,1-dioxido-4-thiomorpholinyl)ethanone
(8c)
The compound was obtained
as a light yellow powder
at ambient temperature. The
yield was 64 % starting from
2-bromo-1-(1,1-dioxidothio-
morpholino)ethanone and 58
% starting from thiomorpholine-
1,1-dioxide.
The compound is generally poorly soluble in common solvents, and is
previously unreported15
9.7.1. Experimental procedure
To a 250 mL round bottom flask containing 2-bromo-1-(1,1-dioxidothiomorpholino)-
ethanone (1.928 g, 7.53 mmol, 1 eq), were added through a solid addition funnel
N,N’-ditosylhydrazine (5.129 g, 15.07 mmol, 2 eq), THF (50 mL) and an oval
stir bar (3.5 × 1.5 cm). The suspension was cooled on an ice/water bath with
stirring (400 rpm) for a period of 15 minutes, upon which a solution of 1,1,3,3-
tetramethylguanidine (4.337 g, 37.65 mmol, 5 eq) in THF (10 mL) was added in
bulk. The white suspension quickly became yellow, and was then stirred for a
period of 70 minutes, before adding Et2O (100 mL) causing the disappearance
of the yellow colour from the THF/Et2O phase, as the product was no longer
soluble. Removal of some of the Et2O under reduced pressure, brought the
yellow colour back to the liquid phase in the suspension. The mixture was filtered
on a Büchner-funnel and the filter cake washed with THF/Et2O (2:1, 75 mL) and
THF (30 mL), leaving an almost white filter cake.
A preliminary purification was performed by adding Celite (3 tablespoons) to
the filtrate, and evaporating the solvents under reduced pressure at 20 °C. The
resulting slightly sticky powder, was suspended in CH2Cl2 (15 mL) and loaded
on top of 1 cm of sea-sand covering a column (8.0 × 3.5 cm) of silica gel packed in
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CH2Cl2. A yellow band was eluted with MeOH/CH2Cl2 (5:95). To this fraction
was added silica gel (2 tablespoons) and the solvents evaporated, leaving a pale
yellow powder. The powder was loaded on top of a column (5.5 × 3.5 cm) of silica
gel packed in CH2Cl2, and the product slowly eluted with CH2Cl2 and from the
point of elution CHCl3. The solvent expenditure was 1.6 L. The solvents were
evaporated under reduced pressure at or below room temperature affording
0.987 g (64 %) of a pale yellow powder which was stored at −20 °C.
XRD crystal growth
Crystals suitable for X-ray crystallography were grown by slow evaporation of
a solution of 4.0 mg of the compound in 500 µL of CH2Cl2 placed in a 2.5 ml
vial which was capped and a pinhole (0.5 mm) made in the cap to allow for slow
evaporation. After approximately 48 hours in the dark at ambient temperature a
head of yellow needles had grown. A crystal measuring 0.8 × 0.3 × 0.2 mm was
selected and the data were recorded at 105 K. The available crystallographic data
are included in the appendix.
9.7.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 5.13 (s, 1H), 3.94 – 3.80 (m, 4H), 3.07 – 2.97
(m, 4H)
• 13C-NMR (75 MHz, CD2Cl2) δ 165.1, 52.4 (2C), 47.2, 42.8 (2C)
• MS (EI) m/z (% rel. int.) 205 (1), 204 (2), 203 (M+, 19), 175 (2), 162 (5), 134
(21), 118 (6), 111 (5), 83 (100), 70 (30), 69 (94)
• HRMS (EI) Calcd. for C6H9N3O3S) [M
+]: 203.0365; found 203.0366 (−0.7
ppm)
• TLC (SiO2, 5 × CH2Cl2) R f : 0.33
• Melting point: 165 – 176 °C (decomposition)
96
1,1,3,3-tetramethylguanidine p-toluenesulfinate
9.8. 1,1,3,3-tetramethylguanidine p-toluenesulfinate
9.8.1. Experimental procedure and XRD crystal growth
The precipitation of this salt formed
during the preparations of the α-diazo-
acetamides as described in their ex-
perimental procedures. In one instance
the precipitate was weighed dry and
it accounted for 98 %w of the theo-
retical amount. A small amount of the
precipitation was immediately dried
and stored under an argon atmosphere
to ensure a low degree of oxidation
before submitting the sample to mass
spectrometry (ESI).
The crystal mass was isolated by
filtration of an acetonitrile solution
also containing 2-diazo-1-(1,1-dioxido-
4-thiomorpholinyl)ethanone, were thick
needles had formed overnight at 4 °C. A
small crystal measuring 0.6 × 0.4 × 0.3
mm was selected for X-ray crystallog-
raphy, and the data recorded at 105 K.
The available crystallographic data are
included in the appendix. See figure 3.6
on page 36 for the structure.
9.8.2. Physical data
Mixture of 1,1,3,3-tetramethylguanidine p-toluenesulfinate and 1,1,3,3-tetramethylguanidine
p-toluenesulfonate (a complete tentative assignment of the peaks can be found on
the spectrum in the appendix):
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• 1H-NMR (200 MHz, CDCl3) δ 8.92 (bs), 7.72 (m), 7.53 (m), 7.11 (m), 7.08 (m),
3.87 (bs), 2.80 (s), 2.28 (s)
• MS (ESI) (Argon then H2O) (ES+) m/z 510/508/506 [2 TMG + 2 HBr + H]+,
403.4 [2 TMG + p−Ts−SO3H + H]+, 387.5 [2 TMG + p−Ts−SO2H + H]+,
313/311 [2 TMG + HBr]+, 231.3 [2 TMG + H]+, 116.2 [TMG + H]+
• MS (ESI) (Argon then H2O) (ES-) m/z 171 [p−Ts−SO3] – , 155 [p−Ts−SO2] –
9.9. 1,1,3,3-tetramethylguanidine p-toluenesulfonate
9.9.1. Experimental procedure and XRD crystal growth
The precipitate isolated as described above, was exposed to air for approximately
72 hours before being submitted to crystallization. Then, a 2.5 ml vial containing
the crude precipitation (4.8 mg) and anhydrous dichloromethane (500 µL) was
capped and a pinhole (0.3 mm) was made in the cap to allow for vapour diffusion
of solvents. This vial was placed inside a 25 ml vial containing Et2O (5 ml)
that was subsequently capped and stored in the dark at ambient temperature
for approximately 48 hours, affording thin transparent needles. A crystal was
selected and the data recorded at 296 K. The structure can be seen in 3.7 on
page 36.
9.9.2. Physical data
This compounds appears as a minor component in a mixture with 1,1,3,3-
tetramethylguanidine p-toluenesulfinate and its spectroscopic details are in-
cluded in the data given above.
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The reported stability of the halogenated α-bromodiazoacetic ethyl esters was
“day-long stability at 0 °C“10f In our experience the 2 – 5 °C temperatures,
obtainable with a common ice/water bath, were not sufficiently low to work
with the halogenated α-diazoacetamides with high reproducibility. Therefore, all
the procedures were carried out at −5 °C using an acetone bath in which the
temperature was controlled by a cryostat.
In the summaries from the mass spectrometry experiments, the R-group in
α, α′-Br2−NR2 refers to the cyclic amine moiety of the respective compound.
10.0.3. General experimental procedure
The diazoacetamide (0.5 mmol, 1.0 eq) was weighed out in a 25 mL pear shaped
flask, the base (0.7 mmol, 1.4 eq) in a 10 mL beaker and the N-halo compound
(0.65 mmol, 1.3 eq) in a weighing funnel. The flask was charged with a small
magnetic stir bar (10 × 2 mm) and CH2Cl2 (2 mL, ambient temperature), and
was subsequently mounted alongside a 250 mL round bottom flask containing
CH2Cl2 (250 mL) in an acetone bath cooled by a cryostat to −5 °C (measured
with an alcohol thermometer at the surface). Stirring (300 RPM) was commenced
and after 2 minutes the base in CH2Cl2 (2 mL, ambient temperature) was added.
After 2 minutes the N-halo compound was added in bulk through the funnel
and the funnel rinsed with CH2Cl2 (1 mL, ambient temperature). The addition
effected a colour change from bright yellow to bright red. While stirring, a short
plug of silica gel (2 × 2 cm) was packed in CH2Cl2 (ambient temperature) in a
fritted flash chromatography column (15 × 2 cm) and mounted inside a holder
which allows for the filling of dry ice around the column (covering ∼ 300°,
leaving an observation window, see figure 10.1 on page 106 in the appendix).
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After stirring for 5 minutes, the thermometer was placed in the 250 mL flask and
CO2(s) was added to the bath until the internal temperature of the CH2Cl2 had
reached −15 °C. The space around the column was filled with dry ice, and the
column equilibrated with CH2Cl2 (−15 °C, 20 mL). The reaction mixture was
then poured directly onto the column, and the flask rinsed with two pipette
volumes of CH2Cl2 (−15 °C). The reaction mixture was run into the column using
pressurized air (ambient temperature), and the column filled up with CH2Cl2
(−15 °C). The column was then run with CH2Cl2 (−15 °C, ∼ 200 mL) under air
pressure to completely elute a bright red band into a 250 mL flask in the cooling
bath. The eluted solution is bright red-pink in colour.
Catalyzed reactions: The flask was charged with a stir bar, capped with
a septum and maintained in the cooling bath at approximately −15 while
degassing with argon (5 minutes). The flask was then taken out of the cooling
bath and a degassed solution of the catalyst in CH2Cl2 (2 mL) was added via
syringe under vigorous stirring. The solution was then left to heat towards room
temperature.
Thermolysis: The flask was placed on the bench without stirring while the
temperature rose from −15 °C towards ambient temperature. The solution
became clear in approximately 60 minutes. For the more polar analogues it was
necessary to add Et2O (5 mL) to the last 50 mL of the eluent to completely collect
the red band. It should be noted that Et2O has a much higher elution strength
than CH2Cl2 under these conditions, and fortunately, it does not seem to interfere
with the C-H insertion reaction at this concentration.
Yield measurement using an internal standard: The reactions were left to
expire overnight, before evaporating the solvent under reduced pressure at 20 °C.
0.5 molar equivalents of 2-naphthaldehyde was then added and the weight
noted, before dissolving the entire crude material in CDCl3. The solution was
transferred to an NMR-tube and a 1H-NMR spectrum recorded.
The CO2(s)-cooled column used in this procedure, has been illustrated at the
end of this chapter. See figure 10.1 on page 106.
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6-bromo-1-azabicyclo[3.2.0]heptan-7-one (1e)
10.1. 6-bromo-1-azabicyclo[3.2.0]heptan-7-one (1e)
The compound was prepared following the general procedure for thermolysis
given above and apparently decomposed at some point before a second 1H-NMR
spectrum was recorded, 48 hours after the first. This is consistent with the rapid
hydrolysis of β-lactams fused with 5-membered rings.27b
10.1.1. Physical data
Crude reaction mixture from thermolysis:
• Partial 1H-NMR (300 MHz, CDCl3) δ 4.395 (d, J = 1.7 Hz, 1H)
• MS (ESI, FT-ICR) (MeCN) m/z 274/272/270 [α, α′-Br2−NR2 + H]+, 210/208
[M + H2O + H]
+ (hydrolysis)
10.2. 7-bromo-1-azabicyclo[4.2.0]octan-8-one (2e)
The compound was prepared following the general procedure for thermolysis
given above.
10.2.1. Physical data
Crude reaction mixture from thermolysis, mixture of cis/trans-isomers:
• 1H-NMR (300 MHz, CDCl3) δ 4.945 (dd, J = 4.43, 1.60 Hz, 1H, cis), 4.395 (d,
J = 1.13 Hz, 1H, trans), 3.805 (dd, J = 13.19 , 4.52 Hz, 1H), 3.50 (ddd, J = 10.69,
4.47, 1.04 Hz, 1H), 2.735 (ddd, J = 13.47, 11.77, 4.33 Hz, 1H), 2.10 (m, 1H),
1.95 – 1.10 (comp, 5H)
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Crude reaction mixture from dirhodium(II) catalysis:
• MS (ESI, Q-TOF) (MeOH) m/z 433/431/429 [C17H20Br2N2O2 + Na]+
(formal carbene dimer), 288/286/284 [α, α′-Br2−NR2 + H]+, 206/204
[M + H]+
Isolated by preparative TLC:
• TLC (SiO2, 1 × Et2O) R f trans: 0.29, cis: 0.19
• MS (EI) m/z (% rel. int.) 205/203 (M+, 6/6), 134/132 (22/22), 124 (100),
121/119 (7/7), 96 (8), 84 (11), 81 (22), 69 (9)
• HRMS (EI) Calcd. for C7H10
79BrNO [M+]: 202.9946; found 202.9938 (3.6
ppm)
α, α′-Br2−piperidine acetamide –– a common by-product:
The free induction decay (FID) of this compound in 1H-NMR, had an interesting
undulate shape. The FID is included in the appendix.
• TLC (SiO2, 1 × Et2O) R f 0.54
• 1H-NMR (300 MHz, CDCl3) δ 6.21 (s, HCBr2−NR2), 6.14 (s, HCBr2−NR2),
3.75 – 3.50 (m, 4H), 1.80 – 1.50 (m, 6H)
• MS (EI) m/z (% rel. int.) 287/285/283 (M+, 6/13/6), 206/204 (56/57),
175/173/171 (4/9/4), 122/120 (6/6), 112 (100), 84 (21), 69 (69)
10.3. 8-bromo-1-azabicyclo[5.2.0]nonan-9-one (3e)
The compound was prepared following the general procedure for thermolysis
given above.
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10.3.1. Chromatographic procedure
The diastereomers trans-3e and cis-3e were separated on a column of alumina
(N, 10 × 2.5 cm), using Et2O as the eluent.
10.3.2. Physical data
Isolated by chromatography:
trans-8-bromo-1-azabicyclo[5.2.0]nonan-9-one
• 1H-NMR (300 MHz, CDCl3) δ 4.255 (dd, J = 1.13, 1.13 Hz, 1H), 3.765 (ddd,
J = 9.61, 2.83, 1.70 Hz, 1H), 3.45 – 3.23 (m, 2H), 2.15 – 2.05 (m, 1H), 1.95 –
1.70 (m, 3H), 1.60 – 1.25 (m, 4H)
• 13C-NMR (75 MHz, CDCl3) δ 162.5, 64.6, 45.7, 43.4, 33.7, 29.2, 27.2, 26.6
cis-8-bromo-1-azabicyclo[5.2.0]nonan-9-one
• 1H-NMR (300 MHz, CDCl3) δ 4.905 (ddd, J = 4.62, 1.79, 0.75 Hz, 1H), 3.85
(ddd, J = 10.13, 4.66, 2.17 Hz, 1H), 3.40 – 3.25 (m, 2H), 2.00 – 1.75 (m, 5H),
1.60 – 1.20 (m, 5H)
• 13C-NMR (75 MHz, CDCl3) δ 163.2, 57.1, 47.9, 43.5, 33.3, 28.9, 28.1, 26.7
Crude reaction mixture from thermolysis, mixture of cis/trans-isomers:
• MS (ESI, FT-ICR) (MeCN) m/z 220/218 [M + H]+
• TLC (SiO2, 1 × Et2O) R f trans: 0.49, cis: 0.36, α, α
′-Br2−NR2: 0.65
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10.4. tert-butyl 7-bromo-8-oxo-1,4-
diazabicyclo[4.2.0]octane-4-carboxylate
(4e)
The compound was prepared both following the general procedure for
thermolysis and catalysis given above.
10.4.1. Physical data
Crude reaction mixture from thermolysis:
• Partial 1H-NMR (300 MHz, CDCl3) δ 4.935 (dd, J = 4.52, 1.13 Hz, 1H, cis),
4.495 (d, J = 1.32 Hz, 1H, trans)
• MS (ESI, FT-ICR) (MeCN) m/z 325/323 [M + H2O + H]+ (hydrolysis),
251/249 [M−56 (iso−butene) + H]+ (Boc-degradation pathway to
carboxylate)
10.5. 7-bromo-4-oxa-1-azabicyclo[4.2.0]octan-8-one (6e)
The compound was prepared following the general procedure for thermolysis
given above.
10.5.1. Physical data
Crude reaction mixture from thermolysis:
• Partial 1H-NMR (300 MHz, CDCl3) δ 4.935 (dd, J = 4.52, 1.32 Hz, 1H, cis),
4.485 (d, J = 1.32 Hz, 1H, trans)
104
7-bromo-4-thia-1-azabicyclo[4.2.0]octan-8-one 4,4-dioxide (8e)
• MS (ESI, FT-ICR) (MeCN) m/z 415/413/411 [C12H16Br2N2O4 + H]+
(formal carbene dimer), 208/206 [M + H]+
10.6. 7-bromo-4-thia-1-azabicyclo[4.2.0]octan-8-one
4,4-dioxide (8e)
The compound was prepared following the general procedure for thermolysis
given above.
10.6.1. Physical data
Crude reaction mixture from thermolysis:
• Partial 1H-NMR (300 MHz, CDCl3) δ 5.20 (dd, J = 4.71, 1.32 Hz, 1H, cis),
4.70 (d, J = 1.51 Hz, 1H, trans)
• MS (ESI, FT-ICR) (MeCN) m/z 274/272 [M + H2O + H]+ (hydrolysis)
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Figure 10.1.: An illustration of the column with a compartment for CO2(s)
106
11. Synthesis of the methacrylonitrile
copolymers
11.1. General experimental procedure for the free radical
suspension copolymerization reactions
A 250 mL three-necked round bottom flask was charged with an oval stir bar
(3.5 × 1.5 cm), potassium iodide (40 mg, aqueous phase polymerization
inhibitor) and 0.5 %wt aqueous polyvinyl alcohol (Mw ≈ 205 000 and 88 %
hydrolysis, 130 mL). All the monomers S/MAN/DVB or MAN/DVB were
weighed out in a beaker, 2,2’-Azobis-(2-methylbutyronitrile) (AMBN) (200 mg,
1 %wt in relation to all the monomers) was added followed by the diluent
mixture (toluene, cyclohexanol or 2-ethylhexanol) and the beaker swirled until
everything had dissolved. This mixture was gently added to aqueous phase
through a funnel while stirring (700 rpm). The flask was flushed with nitrogen
for a period of 5 minutes, before heating to 75 °C (mantle temperature) and
stirring for a period of 19 hours.
The heat was turned off and stirring reduced (500 rpm) while cooling. The
mixture was then poured into MeOH (250 mL) in a beaker and the mixture
vigorously swirled. When the material had settled the MeOH was decanted and
another portion of MeOH (250 mL) added. The mixture was swirled, left to
settle, most of the MeOH was decanted and the material filtered on a Büchner
funnel. The filter cake was washed with H2O (3 × 800 mL) and acetone (1 × 200
mL) before being spread out in a bowl to dry in air. After 24 hours, the now
free-flowing beads weighed 95 – 99 % of the starting material. The obtained
beads were stored in glass jars with PTFE caps, protected from direct sunlight.
The beads from II (see table 13.1) are displayed in figure 13.2 on page 117.
107

12. Synthesis of the dirhodium(II)
catalysts
12.1. Tetrakis µ-caprolactamato dirhodium(II)
12.1.1. Experimental procedure
An oven dried 50 mL round bottom flask containing 40 mL of chlorobenzene
was degassed for a period of 5 minutes under stirring before adding anhydrous
Rh2(OAc)4 (0.199 g, 0.45 mmol, 1.0 eq) and e-caprolactam (1.028 g, 9.08 mmol,
20.2 eq) under stream of argon. The addition of the lactam caused a colour
change from deep green to deep blue. The flask was fitted with an oven dried,
degassed Soxhlet extraction apparatus in which the thimble was charged with
an oven dried mixture of Na2CO3 and sand (5 g, 3:1 ratio). A degassed reflux
condenser was fitted on top of the Soxhlet apparatus and the mixture was
vigorously stirred while heating to 160 °C (mantle temperature) When the first
extraction cycle was observed, the temperature was reduced to 155 °C (mantle
temperature) and the mixture stirred for a period of 46 hours yielding a dark
turquoise solution. The solvent was then evaporated under reduced pressure at
40 °C to give dark purple solid. This solid was dissolved in MeOH (10 mL) and
loaded onto a 13 × 1.5 cm column of the methacrylonitrile copolymer beads
from run II described in section 13.1 on page 114 and prepared following the
general procedure given above. Elution with MeOH (50 mL) separated an
almost clear first fraction, which was discarded. The next 50 mL separated a
purple band, which eluted, and the eluent was again colourless. Elution with
MeCN/MeOH (100 mL, 1:4) gave a purple fraction which turned to a blue solid
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upon evaporation under reduced pressure at 40 °C. The weight was 0.238 g
(71 %, assuming the formula Rh2(cap)4 · 2 MeCN)
12.1.2. Physical data
• 1H-NMR (300 MHz, CD3CN) δ 2.46 (d, J = 2.1 Hz, 30H), 2.025 (q, J = 2.2
Hz), 2.02 (s, 6H)
12.2. cis-M/P-Rh2(µ−O2CCH3)2[Ph2P(C6H4)]2(CH3CN)2
12.2.1. Experimental procedure
A 50 mL round bottom flask was charged with Rh2(OAc)4 · 2 H2O (0.200 g, 0.42
mmol, 1.0 eq) and acetic acid (30 mL) and fitted with a reflux condenser capped
by a rubber septum. PPh3 (0.238 g, 0.91 mmol, 2.2 eq) was weighed out a
weighing paper. The deep green solution was degassed with argon for a period
of 10 minutes and the triphenylphosphine was added under a continuous flow
of argon, giving a bright red suspension. This suspension was heated to reflux in
a heating mantle and stirred at 125 °C (mantle temperature) for a period of 3
hours. The heat was turned off and the now purple suspension was allowed to
cool while stirring for 17 hours. The suspension was concentrated under
reduced pressure to approximately 10 mL and filtered on a Büchner funnel. The
filter cake was washed with a few drops of acetic acid, to give 0.245 g (60 %) a
light purple powder with some dark purple needles. The mother liquor was
concentrated under reduced pressure to a volume of approximately 5 mL and
placed in a freezer at −15 °C until frozen. The frozen cake was divided into
pieces, placed on a Büchner funnel, where it subsequently melted leaving a
purple powder. This powder was washed with a few drops of acetic acid to give
a second crop of 0.067 g (16 %). Both crops were pure by 1H-NMR and
31P-NMR, and were subsequently mixed and stored in a capped glass jar in an
air atmosphere. The total yield was 77 %.
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cis-M/P-Rh2(µ−O2CCH3)2[Ph2P(C6H4)]2(CH3CN)2
12.2.2. Physical data
• 1H-NMR (300 MHz, CD2Cl2) δ 7.80 – 6.50 (comp, 28H), 2.21 (s, 6H), 2.14 (s,
6H)
• 13C-NMR (75 MHz, CD2Cl2) δ 182.1, 182.1, 145.6, 140.3, 140.1, 134.6, 134.5,
134.4, 133.9, 133.8, 133.6, 133.2, 133.0, 129.4, 129.4, 128.8, 128.4, 127.8, 127.7,
127.5, 127.4, 120.5, 120.5, 116.0, 22.8, 3.4
• 31P-NMR (75 MHz, CD2Cl2) δ 19.3 (d, J = 156.3 Hz)
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13. Purification of the dirhodium(II)
catalysts
The method of choice for the work-up and purification of dirhodium(II)
complexes, depend on the solubility, crystallinity, stability and, linked to all of
the aforementioned, what axial ligands are present in the product complex. In
general, the members of each catalyst family (cf. figure 2.1 on page 16) are
worked up and purified in a similar way, owing to their similar synthesis
protocols and chemical properties. Each catalyst family will thus present a set of
axial ligands, or a lack thereof, after work-up depending on the method applied.
Recrystallization is often only practically possible if the axial seats are occupied.
A complex with volatile axial ligands e.g. acetonitrile can be heated under high
vacuum to remove these, given that the complex is sufficiently thermally stable,
or they may be displaced in a weakly coordinating solvent (cf. discussion in
section 2.3 on page 15).
The use of column chromatography on silica gel has been employed in the
purification of all three families, but is most commonly reported for
dirhodium(II) carboxylates and orthometalated phosphines. The preferred
methods for the preparative purification of dirhodium(II) carboxamidates are
recrystallization or cation exchange-type chromatography on a column packed
with J.T. Baker BAKERBOND Cyano 40 um prep LC pacKing medium.52 This
column packing medium is an amorphous silica gel whose free Si-OH groups
have been capped by a reaction with (4-trichlorosilyl) butanenitrile and
chlorotrimethylsilane. Thus, when the reaction mixture is applied to the column,
the free nitrile groups bind to the dirhodium(II) carboxamidate through its axial
seats (cf. discussion in section 2.3). This near permanently retards the complex.
Taking advantage of this coordination, the excess ligand from the ligand
exchange reaction could be eluted using MeOH, leaving behind only
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dirhodium(II) species capable of axial coordination. The pure catalyst could
then be eluted by the addition of MeCN to the eluent, as the the nitrile groups
on the stationary phase are outcompeted by those in the mobile phase. Having
followed the reaction to completion by HPLC, the eluted substance could safely
be assumed to consist solely of the cis-2,2 dirhodium(II) carboxamidate.25l
Most dirhodium(II) complexes will bind nitrile groups axially from a ligand-free
state or in favour of weaker donors e.g. the axially hydrogen bonded acetic acid
molecules in the products obtained from the reaction of dirhodium(II)
tetraacetate dihydrate and arylphosphines in refluxing acetic acid. The strength
of the coordination should vary with the Lewis acidity of the complex, but given
that the technique works for the least Lewis acidic family of the dirhodium(II)
catalysts used in diazo chemistry, there is promise of some generality to this
method. In contrast to this, the use of this method of purification has not been
reported for members from other dirhodium(II) catalyst families. Possibly this
owes to the cost of the BAKERBOND Cyano medium. We hypothesized that the
inclusion nitrile groups in macroporous copolymer beads could be achieved
using free radical suspension copolymerization based on feedstock monomers
like acrylonitrile/methacrylonitrile and divinylbenzene. The preparation of
macroporous methacrylonitrile-divinylbenzene beads and the purification of the
synthesized dirhodium(II) catalysts using the obtained beads, is the topic of the
next section.
13.1. The application of methacrylonitrile copolymer
beads in the purification of dirhodium(II) catalysts
A survey of the literature showed that the suspension copolymerization of
styrene (S) – divinylbenzene (DVB), acrylonitrile (AN) – divinylbenzene (DVB)
or all three had been investigated with respect to the sorption properties,
porosity and specific surface area obtained with respect to the monomer
fractions, crosslinking degree and porogens (diluents).53 Additionally, the use of
S/AN/DVB and AN/DVB copolymer beads as supports for transition metal
catalysts has been reported.54 The joint results of the authors were used to
adjust our starting parameters. Due to the AN monomer being carcinogenic, we
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catalysts
opted for methacrylonitrile (MAN).
Run S (%wt) MAN (%wt) DVB Porogen (diluent) Xv/v
I 58 42 0.25 %mol Toluene/Cyclohexanol 5:5
II - 50 50 %wt Toluene/2-Ethylhexanol 9:1
III - 50 50 %wt Toluene/2-Ethylhexanol 5:5
Figure 13.1.: Variations in monomer ratios and porogens(diluents)
Three batches of polymers were prepared using the conditions give in table 13.1.
The experimental details of the suspension polymerization reactions can be
found in the experimental section. In all the runs, the suspension polymerization
gave round beads of even size (the size was not measured). The beads from the
first run were glass-like and almost transparent. The beads from the subsequent
runs were white and opaque. To our satisfaction, the beads functioned as one
should expect from reading about the use of the BAKERBOND Cyano medium.
It appears therefore that that the nitrile groups are sufficiently available within
the crosslinked network, although they are located at a shorter distance from the
“backbone“ than in the post-modified silica gel. The material obtained in the
first run was not suited as a chromatographic medium, because it needed to be
pre-swelled in either THF or CH2Cl2 prior to use, in order to function. This was
not the case for the, presumably more macroporous beads from the last two
runs. The retention of the of dirhodium(II) catalyst , which was used for testing
the beads between the runs, was also somewhat higher on the material II and III,
as compared to I. The handling of the beads was most convenient with I and II,
presumably due to the increase in the fraction of 2-ethylhexanol in the porogen
mixture, which left the beads from III more sensitive to static electricity and
with a slightly more amorphous appearance.
The beads II were put to a real-life test in the purification of Rh2(cap)4. The
reported procedure uses 35 g of the BAKERBOND Cyano chromatography
medium per gram of catalyst, and the catalyst could be eluted in MeOH. In our
case, 42 grams of II per gram catalyst, in a column (13 × 1.5 cm) was used, and
the catalyst band was eluted by adding MeCN to the eluent, after having eluted
the column with a few column volumes of MeOH. Upon adding MeCN to the
eluent, a colour change was observed, possibly owing to the coordination of free
nitrile groups replacing the ones in the stationary phase.
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In figure 13.2 on the next page the colour change is shown for the complex
Rh2(OAc)2(pc)2 ·CH3COOH (pc = orthometalated PPh3), recently loaded in
MeOH (A), and at the beginning of the elution with MeOH/MeCN (B).
As has been been discussed, the interaction with the nitrile group is stronger
for the more Lewis acidic catalysts. Thus, the challenge with this system is the
sufficient retention of the more weakly Lewis acidic catalysts. The result with
one of the weaker Lewis acids among the dirhodium(II) catalysts utilized in
diazo chemistry (Rh2(cap)4), were positive. Worthy of note, is the fact that in the
reported procedures for the purification of other dirhodium(II) carboxamidates
on the BAKERBOND Cyano medium, MeCN needs to be added to elute the
catalysts. The same was the case with the Rh2(OAc)2(pc)2 ·CH3COOH used in
the testing of obtained copolymer beads. In conclusion, the preliminary results
with this system, hold promise of a low-cost, widely applicable system for the
purification of the dirhodium(II) catalysts.
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Figure 13.2.: The methacrylonitrile beads in action (left) and under the camera (right)
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1H-NMR – N-bromo-2-pyrrolidone
14. NMR Spectra
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N-bromo-2-pyrrolidone – 13C-NMR
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1H-NMR – N-bromophthalimide
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N,N’-ditosylhydrazine – 1H-NMR
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13C-NMR – N,N’-ditosylhydrazine
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2-bromo-1-(pyrrolidin-1-yl)ethanone – 1H-NMR
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13C-NMR & DEPT-135 – 2-bromo-1-(pyrrolidin-1-yl)ethanone
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2-bromo-1-(piperidin-1-yl)ethanone – 1H-NMR
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13C-NMR & DEPT-135 – 2-bromo-1-(piperidin-1-yl)ethanone
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1-(azepan-1-yl)-2-bromoethanone – 1H-NMR
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13C-NMR & DEPT-135 – 1-(azepan-1-yl)-2-bromoethanone
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1-(azepan-1-yl)-2-bromoethanone – HMQC (1J13C,1 H)
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1H-NMR – tert-butyl 4-(2-bromoacetyl)piperazine-1-carboxylate
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tert-butyl 4-(2-bromoacetyl)piperazine-1-carboxylate – 13C-NMR & DEPT-135
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1H-NMR – N,N’-bis(2-bromoacetyl)piperazine
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N,N’-bis(2-bromoacetyl)piperazine – 13C-NMR & DEPT-135
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1H-NMR – 2-bromo-1-morpholinoethanone
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2-bromo-1-morpholinoethanone – 13C-NMR & DEPT-135
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1H-NMR – 2-bromo-1-(1,1-dioxidothiomorpholino)ethanone
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2-bromo-1-(1,1-dioxidothiomorpholino)ethanone – 13C-NMR & DEPT-135
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
or
m
al
iz
ed
 In
te
ns
ity
ACETONITRILE-d3
27.58, XX
ACETONITRILE-d3
166.47, X
1.29
27.81(11)
41.57(5,3)
45.71(3,5)52.07(6,2)
52.26(2,6)
118.26
163.17(9)
Acquisition Time (sec) 1.8219 Comment C13CPD CD3CN D: {UIO\aasmuk} 57 Frequency (MHz) 75.48 Nucleus 13C
Number of Transients 2048 Origin DPX300 Original Points Count 32768 Points Count 32768 Pulse Sequence zgpg30
Receiver Gain 11585.20 SW(cyclical) (Hz) 17985.61 Solvent ACETONITRILE-d3 Spectrum Offset (Hz) 7617.4600
Spectrum Type STANDARD Sweep Width (Hz) 17985.06 Temperature (degree C) 25.160
N
4
39
5
O
10
11
Br
12
2
6
S
1
O
7
O
8
Formula C
6
H
10
BrNO
3
S
FW 256.1175
54 52 50 48 46 44 42 40 38 36 34 32 30 28 26 24
Chemical Shift (ppm)
-1.0
-0.9
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
N
or
m
al
iz
ed
 In
te
ns
ity
27.58, X
From 13C Spectrum
27.81(11)
41.57(5,3)
45.71(3,5)52.06(6,2)
52.26(2,6)
Acquisition Time (sec) 1.8219 Comment C13DEPT135 CD3CN D: {UIO\aasmuk} 57 Frequency (MHz) 75.48 Nucleus 13C
Number of Transients 512 Origin DPX300 Original Points Count 32768 Points Count 32768 Pulse Sequence dept135
Receiver Gain 13004.00 SW(cyclical) (Hz) 17985.61 Solvent ACETONITRILE-d3 Spectrum Offset (Hz) 7617.6548
Spectrum Type DEPT135 Sweep Width (Hz) 17985.06 Temperature (degree C) 25.160
N
4
39
5
O
10
11
Br
12
2
6
S
1
O
7
O
8
Formula C
6
H
10
BrNO
3
S
FW 256.1175
155
1H-NMR – 2-diazo-1-(pyrrolidin-1-yl)ethanone
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2-diazo-1-(pyrrolidin-1-yl)ethanone – 13C-NMR & DEPT-135
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Crude 1H-NMR – 2-diazo-1-(pyrrolidin-1-yl)ethanone
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2-diazo-1-(piperidin-1-yl)ethanone – 1H-NMR
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13C-NMR & DEPT-135 – 2-diazo-1-(piperidin-1-yl)ethanone
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1H-NMR – 1-(azepan-1-yl)-2-diazoethanone
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1-(azepan-1-yl)-2-diazoethanone – 13C-NMR & DEPT-135
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HMQC (1J13C,1 H) – 1-(azepan-1-yl)-2-diazoethanone
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tert-butyl 4-(2-diazoacetyl)piperazine-1-carboxylate – 1H-NMR
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13C-NMR & DEPT-135 – tert-butyl 4-(2-diazoacetyl)piperazine-1-carboxylate
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N,N’-bis(2-diazoacetyl)piperazine – 1H-NMR
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13C-NMR – N,N’-bis(2-diazoacetyl)piperazine
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2-diazo-1-morpholinoethanone – 1H-NMR
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13C-NMR & DEPT-135 – 2-diazo-1-morpholinoethanone
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2-diazo-1-morpholinoethanone – HMQC (1J13C,1 H)
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1H-NMR – 2-diazo-1-(1,1-dioxido-4-thiomorpholinyl)ethanone
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2-diazo-1-(1,1-dioxido-4-thiomorpholinyl)ethanone – 13C-NMR
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1H-NMR – 1,1,3,3-tetramethylguanidine sulfinate (and sulfonate)
10.0
9.5
9.0
8.5
8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
C
hem
ical S
hift (ppm
)
0 0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Normalized Intensity
3.43
14.10
0.45
2.28
2.00
0.26
2.13
C
H
LO
R
O
FO
R
M
-d
2a,3a,5a,6a
12a,13a,15a,16a
12a,13a,15a,16a
2a,3a,5a,6a
2.28(9a,9b,9c,19a,19b,19c)
2.80(23a,23b,23c,24a,24b,24c,27a,27b,27c,29a,29b,29c)
3.87(28a,28b)
7.07
7.09
7.12
7.26
7.52
7.54
7.70
7.73
8.92(28a,28b)
Acquisition
 Tim
e
 (sec)
5.3084
Com
m
ent
P
R
O
TO
N
 C
D
C
l3 D
: {U
IO
\aasm
uk} 12
Frequency
 (MHz)
300.13
N
ucleus
1H
N
um
ber
 of
 Transients
16
O
rigin
D
P
X
300
O
riginal
 Points
 Count
32768
Points
 Count
32768
Pulse
 Sequence
zg30
R
eceiver
 G
ain
114.00
SW
(cyclical)
 (Hz)
6172.84
Solvent
C
H
LO
R
O
FO
R
M
-d
Spectrum
 O
ffset
 (Hz)
1846.7491
Spectrum
 Type
S
TA
N
D
A
R
D
Sweep
 W
idth
 (Hz)
6172.65
Tem
perature
 (degree
 C)
25.160
Form
ula
C
19 H
28 N
3 O
5 S
2
FW
442.5733 (155.1948+171.1942+116.1842)
2
1
3
6
4
5
9
S7 O8
O
-
10
H2a
H3a
H6a
H5a
H9a
H9b
H9c
12
11
13
16
14
15
19
S17
O18
O
-
21 O20
H12a
H13a
H16a
H15a
H19a
H19b
H19c
H28a
23
24 N22
27
29
25 N +28
N26
H23a H23b
H23c
H24a
H24c
H24b
H27a
H27cH27b
H29a
H29b
H29c
H28b
174
Crude 6-bromo-1-azabicyclo[3.2.0]heptan-7-one – 1H-NMR
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1H-NMR – Crude 7-bromo-1-azabicyclo[4.2.0]octan-8-one - NBS
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Crude 7-bromo-1-azabicyclo[4.2.0]octan-8-one - NBP – 1H-NMR
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1H-NMR – Crude 8-bromo-1-azabicyclo[5.2.0]nonan-9-one
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Crude tert-butyl 7-bromo-8-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxylate – 1H-NMR
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1H-NMR – Crude 7-bromo-4-oxa-1-azabicyclo[4.2.0]octan-8-one
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Crude 7-bromo-4-thia-1-azabicyclo[4.2.0]octan-8-one 4,4-dioxide – 1H-NMR
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1H-NMR – Crude; carbene dimer from catalytic decomposition of 2d with Cu(acac)2
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7-bromo-1-azabicyclo[4.2.0]octan-8-one – 1H-NMR
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1H-NMR – 1-(piperidin-1-yl)-2-tosylethanone
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1-(piperidin-1-yl)-2-tosylethanone – 13C-NMR
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1H-NMR – 2,2-dibromo-1-(piperidin-1-yl)ethanone
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2,2-dibromo-1-(piperidin-1-yl)ethanone – FID
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1H-NMR – cis-8-bromo-1-azabicyclo[5.2.0]nonan-9-one
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cis-8-bromo-1-azabicyclo[5.2.0]nonan-9-one – 13C-NMR & DEPT-135
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1H-NMR – trans-8-bromo-1-azabicyclo[5.2.0]nonan-9-one
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trans-8-bromo-1-azabicyclo[5.2.0]nonan-9-one – 13C-NMR & DEPT-135
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1H-NMR – cis-2,2-Tetrakis µ-caprolactamato dirhodium(II)
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
C
hem
ical S
hift (ppm
)
0 0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Normalized Intensity
18.52
30.00
A
C
E
TO
N
ITR
ILE
-d3
S
inglet
J=2.20 H
z
J=2.05 H
z
J=2.20 H
z
J=2.20 H
z
M
02(d)
M
01(q)2.01
2.02(37,40)
2.02
2.03
2.03
2.46
2.46
Acquisition
 Tim
e
 (sec)
13.6315
Com
m
ent
P
R
O
TO
N
 C
D
3C
N
 D
: {U
IO
\aasm
uk} 21
Frequency
 (MHz)
300.13
N
ucleus
1H
N
um
ber
 of
 Transients
256
O
rigin
D
P
X
300
O
riginal
 Points
 Count
32768
Points
 Count
32768
Pulse
 Sequence
zg30
R
eceiver
 G
ain
1625.50
SW
(cyclical)
 (Hz)
2403.85
Solvent
A
C
E
TO
N
ITR
ILE
-d3
Spectrum
 O
ffset
 (Hz)
1074.3115
Spectrum
 Type
S
TA
N
D
A
R
D
Sweep
 W
idth
 (Hz)
2403.77
Tem
perature
 (degree
 C)
25.160
39
R
h1Rh2
4
10
N5
O3
N27
O34
20
N21 O19
12N13
O11
N35
N38
C
H
3
40
36
C
H
3
37
6
7
89
33
28
29
30
31
32
22
23
24
25
26
14
15
16
17
18
Form
ula
C
28 H
46 N
6 O
4 R
h
2
FW
736.5136
cis-2,2
 isom
er
a
ssu
m
ed
192
cis-M/P-Rh2(µ−O2CCH3)2[Ph2P(C6H4)]2(CH3CN)2 – 1H-NMR
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13C-NMR – cis-M/P-Rh2(µ−O2CCH3)2[Ph2P(C6H4)]2(CH3CN)2
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cis-M/P-Rh2(µ−O2CCH3)2[Ph2P(C6H4)]2(CH3CN)2 – HMQC (1J13C,1 H)
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31P-NMR – cis-M/P-Rh2(µ−O2CCH3)2[Ph2P(C6H4)]2(CH3CN)2
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Crude; thermolysis of α-Br-EDA in neat styrene – 1H-NMR
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1H-NMR – Thermolysis product of α-Br-EDA in neat styrene (w/ internal standard)
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15. X-ray Diffraction Data
201
XRD Data – N,N’-bis(2-diazoacetyl)piperazine (5c)
N,N  -bis(2-diazoacetyl)piperazine   - 5c
Bond precision: C-C = 0.0015 Å Wavelength=0.71073
Cell: a=4.0630(7) b=9.0941(15) c=13.231(2)
alpha=90 beta=94.453(2) gamma=90
Temperature: 105 K
Calculated Reported
Volume 487.40(14) 487.38(14)
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C8 H10 N6 O2 C8 H10 N6 O2 
Sum formula C8 H10 N6 O2 C8 H10 N6 O2 
Mr 222.22 222.22 
Dx,g cm-3 1.514 1.514 
Z 2 2 
Mu (mm-1) 0.115 0.115 
F000 232.0 232.0
F000' 232.09 
h,k,lmax 5,12,17 5,11,17
Nref 1263 1190 
Tmin,Tmax
Tmin'
Correction method= Not given
Data completeness= 0.942 Theta(max)= 28.660
R(reflections)= 0.0345( 1013) wR2(reflections)= 0.0900( 1190)
S = 1.052 Npar= 73
202
2-diazo-1-(1,1-dioxido-4-thiomorpholinyl)ethanone (8c) – XRD Data
2-diazo-1-(1,1-dioxido-4-thiomorpholinyl)ethanone - 8c
Bond precision: C-C = 0.0020 Å Wavelength=0.71073
Cell: a=5.2729(3) b=20.1349(11) c=7.8683(4)
alpha=90 beta=95.171(2) gamma=90
Temperature: 105 K
Calculated Reported
Volume 831.97(8) 831.97(8)
Space group P 21/n P 21/n 
Hall group -P 2yn -P 2yn 
Moiety formula C6 H9 N3 O3 S C6 H9 N3 O3 S 
Sum formula C6 H9 N3 O3 S C6 H9 N3 O3 S 
Mr 203.23 203.22 
Dx,g cm-3 1.622 1.622 
Z 4 4 
Mu (mm-1) 0.367 0.367 
F000 424.0 424.0
F000' 424.68 
h,k,lmax 8,33,13 8,32,13
Nref 4152 3933 
Tmin,Tmax
Tmin'
Correction method= Not given
Data completeness= 0.947 Theta(max)= 36.760
R(reflections)= 0.0570( 3027) wR2(reflections)= 0.1688( 3933)
S = 1.115 Npar= 128
203
XRD Data – TMG p-toluenesulfinate
1,1,3,3-tetramethylguanidine  p  -toluenesulfinate  
Bond precision: C-C = 0.0016 Å Wavelength=0.71073
Cell: a=11.0959(8) b=7.4038(5) c=17.1944(13)
alpha=90 beta=92.115(1) gamma=90
Temperature: 105 K
Calculated Reported
Volume 1411.59(18) 1411.59(18)
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C5 H14 N3, C7 H7 O2 S C5 H14 N3, C7 H7 O2 S 
Sum formula C12 H21 N3 O2 S C12 H21 N3 O2 S 
Mr 271.39 271.38 
Dx,g cm-3 1.277 1.277 
Z 4 4 
Mu (mm-1) 0.229 0.229 
F000 584.0 584.0
F000' 584.70 
h,k,lmax 14,9,22 14,9,22
Nref 3492 3375 
Tmin,Tmax
Tmin'
Correction method= Not given
Data completeness= 0.966 Theta(max)= 28.250
R(reflections)= 0.0302( 3026) wR2(reflections)= 0.0852( 3375)
S = 1.047 Npar= 174
204
TMG p-toluenesulfonate – XRD Data
1,1,3,3-tetramethylguanidine  p  -toluenesulfonate  
Bond precision: C-C = 0.0066 Å Wavelength=0.71073
Cell: a=11.185(3) b=7.648(2) c=17.415(5)
alpha=90 beta=93.169(4) gamma=90
Temperature: 296 K
Calculated Reported
Volume 1487.5(7) 1487.5(8)
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C5 H14 N3, C7 H7 O3 S C5 H14 N3, C7 H7 O3 S 
Sum formula C12 H21 N3 O3 S C12 H21 N3 O3 S 
Mr 287.39 287.38 
Dx,g cm-3 1.283 1.283 
Z 4 4 
Mu (mm-1) 0.226 0.226 
F000 616.0 616.0
F000' 616.74 
h,k,lmax 13,9,20 13,9,20
Nref 2624 2615 
Tmin,Tmax
Tmin'
Correction method= Not given
Data completeness= 0.997 Theta(max)= 25.040
R(reflections)= 0.0669( 1587) wR2(reflections)= 0.1889( 2615)
S = 1.087 Npar= 186
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tert-Butyl 4-(2-diazoacetyl)piperazine-1-
carboxylate
A˚smund Kaupang, Carl Henrik Go¨rbitz* and Tore Hansen
Department of Chemistry, University of Oslo, PO Box 1033 Blindern, N-0315 Oslo,
Norway
Correspondence e-mail: c.h.gorbitz@kjemi.uio.no
Received 22 April 2010; accepted 3 May 2010
Key indicators: single-crystal X-ray study; T = 105 K; mean (C–C) = 0.002 A˚;
R factor = 0.038; wR factor = 0.103; data-to-parameter ratio = 15.9.
The title crystal structure, C11H18N4O3, is the first diazo-
acetamide in which the diazoacetyl group is attached to an N
atom. The piperazine ring is in a chair form and hence the
molecule has an extended conformation. Both ring N atoms
are bonded in an essentially planar configuration with the sum
of the C—N—C angles being 359.8 (2) and 357.7 (2). In the
crystal structure, the O atom of the diazoacetyl group accepts
two H atoms from C—H donors, thus generating chains of
weak hydrogen-bonded R2
1(7) rings.
Related literature
For the only other reported synthesis of a diazoacetamide in
the Chemical Abstracts Service (CAS, American Chemical
Society, 2008) with a 1,4-diaza six-membered ring, see: Mick-
elson et al. (1996). For other diazoacetamides, see: Ouihia et al.
(1993). For related structures, see: Fenlon et al. (2007); Wang et
al. (2006); Miller et al. (1991). For synthetic details, see:
Kaupang (2010); Toma et al. (2007). For hydrogen-bond
graph-set notation, see: Bernstein et al. (1995). For a
description of the Cambridge Structural Database, see: Allen
(2002).
Experimental
Crystal data
C11H18N4O3
Mr = 254.29
Monoclinic, P21=c
a = 14.654 (10) A˚
b = 10.548 (7) A˚
c = 8.553 (6) A˚
 = 91.122 (6)
V = 1321.8 (15) A˚3
Z = 4
Mo K radiation
 = 0.10 mm1
T = 105 K
0.55  0.42  0.08 mm
Data collection
Bruker APEXII CCD
diffractometer
Absorption correction: multi-scan
(SADABS; Bruker, 2007)
Tmin = 0.870, Tmax = 0.992
7308 measured reflections
2692 independent reflections
2111 reflections with I > 2(I)
Rint = 0.041
Refinement
R[F 2 > 2(F 2)] = 0.038
wR(F 2) = 0.103
S = 1.03
2692 reflections
169 parameters
H atoms treated by a mixture of
independent and constrained
refinement
max = 0.17 e A˚
3
min = 0.23 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C1—H1  O1i 0.946 (17) 2.313 (18) 3.250 (3) 170.6 (14)
C3—H32  O1i 0.99 2.36 3.327 (3) 164
Symmetry code: (i) x; yþ 12;zþ 12.
Data collection: APEX2 (Bruker, 2007); cell refinement: SAINT-
Plus (Bruker, 2007); data reduction: SAINT-Plus; program(s) used to
solve structure: SHELXTL (Sheldrick, 2008); program(s) used to
refine structure: SHELXTL; molecular graphics: SHELXTL; soft-
ware used to prepare material for publication: SHELXTL.
Supplementary data and figures for this paper are available from the
IUCr electronic archives (Reference: LH5033).
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tert-Butyl 4-(2-diazoacetyl)piperazine-1-carboxylate
Å. Kaupang, C. H. Görbitz and T. Hansen
Comment
The tert-butyl 4-(2-diazoacetyl)piperazine-1-carboxylate (I) was prepared as part of a series of diazoacetamides, to be used in
intramolecular C—H insertion reactions (Kaupang, 2010). It was synthesized from tert-butyl 4-(2-bromoacetyl)piperazine-
1-carboxylate by a slight modification of the procedure reported by Toma et al. (2007), employing 1,1,3,3-tetramethylguan-
idine as the base instead of 1,8-diazabicyclo[5.4.0]undec-7-ene.
Diffraction data were first collected at ambient temperature, yielding a structure with a massively disordered six-
membered ring. At 105 K the ring is completely ordered in a well defined chair conformation, Fig. 1.
The diazoacetyl moiety is not an uncommon functional group in organic molecules, however only 15 occurrences were
found in the Cambridge Structural Database (Version 5.31 of November 2009; Allen, 2002), and none where, as here, the
group is attached to a N atom. In only two structures the group sits on a non-aromatic ring (Miller et al., 1991; Fenlon et
al., 2007).
In a model molecule like trimethylamine the N atom is located about 0.45 Å above the plane defined by the three C atoms.
In the structure of (I) N3 is 0.125 (2) Å above the plane defined by C2, C3 and C4, while N4 is only 0.039 (2) Å above the
plane defined by C5, C6 and C7, which essentially shows a planar configuration (sum of C—N—C angles 359.8 (2) °). This
is due to the double bond character of the amidic N3—C2 and N4—C7 bonds measuring 1.3515 (18) and 1.3483 (18) Å,
respectively. An example of a related structure is 1,4-di(chloroacetyl)piperazine (Wang et al., 2006).
In the crystal structure, the O atom of the diazoacetyl group accepts two H atoms from C—H donors, thus generating
chains of hydrogen-bonded R12(7) rings (Bernstein et al., 1995).
Experimental
A 2.5 ml vial containing tert-butyl 4-(2-diazoacetyl)piperazine-1-carboxylate (10.8 mg) and dichloromethane (1000 ml) was
capped and a pinhole (0.5 mm) was made in the cap to allow for vapour diffusion of solvents. This vial was placed inside
a 25 ml vial containing n-pentane (8 ml) that was subsequently capped and stored in the dark at ambient temperature for
approximately 48 hours, affording bright yellow plate-shaped crystals.
Refinement
Coordinates were refined for H1 (bonded to C1), which is involved in the shortest intermolcular interaction. Other H atoms
were positioned with idealized geometry and fixed C–H distances set to 0.98 Å (methyl) or 0.99 Å (methylene). Free rotation
was permitted for the methyl groups. Uiso values were 1.2Ueq of the carrier atom or 1.5Ueq for methyl groups.
supplementary materials
sup-2
Figures
Fig. 1. The asymmetric unit of (I), with atomic numbering indicated, together with selec-
ted atoms of neighbouring molecules connected by weak hydrogen bonds shown as dotted
lines (see Table 1, symmetry operations are -x,1/2+y,1/2-z for O', -x,-1/2+y,1/2-z for H1"
and H32"). Displacement ellipsoids are shown at the 50% probability level with H atoms as
spheres of arbitrary size.
tert-Butyl 4-(2-diazoacetyl)piperazine-1-carboxylate
Crystal data
C11H18N4O3 F(000) = 544
Mr = 254.29 Dx = 1.278 Mg m−3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
a = 14.654 (10) Å Cell parameters from 2404 reflections
b = 10.548 (7) Å θ = 2.4–26.4°
c = 8.553 (6) Å µ = 0.10 mm−1
β = 91.122 (6)° T = 105 K
V = 1321.8 (15) Å3 Plate, yellow
Z = 4 0.55 × 0.42 × 0.08 mm
Data collection
Bruker APEXII CCD
diffractometer 2692 independent reflections
Radiation source: fine-focus sealed tube 2111 reflections with I > 2σ(I)
graphite Rint = 0.041
Detector resolution: 8.3 pixels mm-1 θmax = 26.4°, θmin = 2.4°
Three sets of frames each taken over 0.3° ω rotation
with 20 s exposure time. Detector set at 2θ = 26°,
crystal–to–detector distance 6.00 cm. scans
h = −17→18
Absorption correction: multi-scan
(SADABS; Bruker, 2007) k = −10→13
Tmin = 0.870, Tmax = 0.992 l = −10→10
7308 measured reflections
Refinement
Refinement on F2
Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.038
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.103
H atoms treated by a mixture of independent and
constrained refinement
S = 1.03
w = 1/[σ2(Fo2) + (0.0463P)2 + 0.1671P]
where P = (Fo2 + 2Fc2)/3
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2692 reflections (Δ/σ)max = 0.001
169 parameters Δρmax = 0.17 e Å−3
0 restraints Δρmin = −0.22 e Å−3
Special details
Experimental. Crystallized from dichloromethane and n-pentane.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The
cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds
in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used
for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
O1 0.02567 (7) 0.20344 (9) 0.19361 (12) 0.0353 (3)
O2 0.38950 (6) 0.35633 (9) 0.62995 (11) 0.0296 (2)
O3 0.33388 (6) 0.55670 (8) 0.64091 (11) 0.0294 (2)
N1 −0.14125 (10) 0.34028 (15) −0.00383 (19) 0.0562 (4)
N2 −0.08817 (8) 0.37402 (12) 0.08229 (16) 0.0377 (3)
N3 0.10933 (7) 0.34931 (10) 0.32642 (14) 0.0293 (3)
N4 0.27460 (8) 0.42179 (11) 0.46913 (15) 0.0350 (3)
C1 −0.02502 (10) 0.41229 (14) 0.18201 (17) 0.0324 (3)
H1 −0.0254 (10) 0.4999 (17) 0.2058 (19) 0.039*
C2 0.03721 (9) 0.31392 (13) 0.23569 (16) 0.0276 (3)
C3 0.11676 (9) 0.47080 (12) 0.40835 (18) 0.0301 (3)
H31 0.0971 0.4604 0.5177 0.036*
H32 0.0760 0.5337 0.3568 0.036*
C4 0.17261 (10) 0.25284 (13) 0.38538 (18) 0.0317 (3)
H41 0.1681 0.1763 0.3188 0.038*
H42 0.1561 0.2287 0.4931 0.038*
C5 0.21342 (9) 0.51824 (13) 0.40729 (18) 0.0322 (3)
H51 0.2304 0.5397 0.2990 0.039*
H52 0.2188 0.5960 0.4717 0.039*
C6 0.26896 (10) 0.30251 (13) 0.38538 (19) 0.0349 (4)
H61 0.3104 0.2399 0.4357 0.042*
H62 0.2886 0.3150 0.2763 0.042*
C7 0.33775 (9) 0.43825 (12) 0.58409 (16) 0.0259 (3)
C8 0.39795 (9) 0.59837 (13) 0.76528 (15) 0.0275 (3)
C9 0.36780 (11) 0.73381 (14) 0.79087 (18) 0.0387 (4)
H91 0.3721 0.7811 0.6927 0.058*
H92 0.4073 0.7734 0.8707 0.058*
H93 0.3045 0.7346 0.8258 0.058*
C10 0.49473 (10) 0.59327 (15) 0.70952 (17) 0.0354 (4)
H101 0.4989 0.6386 0.6099 0.053*
H102 0.5129 0.5047 0.6951 0.053*
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H103 0.5354 0.6333 0.7873 0.053*
C11 0.38403 (10) 0.52052 (14) 0.91124 (17) 0.0351 (4)
H111 0.3190 0.5190 0.9358 0.053*
H112 0.4186 0.5583 0.9987 0.053*
H113 0.4055 0.4337 0.8939 0.053*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O1 0.0331 (6) 0.0239 (5) 0.0487 (6) −0.0044 (4) −0.0025 (5) −0.0072 (5)
O2 0.0298 (5) 0.0242 (5) 0.0348 (5) 0.0047 (4) −0.0017 (4) 0.0004 (4)
O3 0.0326 (5) 0.0217 (5) 0.0336 (5) 0.0019 (4) −0.0074 (4) −0.0042 (4)
N1 0.0446 (8) 0.0565 (10) 0.0665 (10) −0.0058 (7) −0.0207 (8) −0.0054 (8)
N2 0.0320 (7) 0.0341 (7) 0.0469 (8) −0.0010 (5) −0.0060 (6) −0.0007 (6)
N3 0.0279 (6) 0.0200 (6) 0.0398 (7) 0.0018 (5) −0.0042 (5) −0.0041 (5)
N4 0.0304 (6) 0.0239 (6) 0.0503 (8) 0.0057 (5) −0.0125 (6) −0.0096 (5)
C1 0.0297 (8) 0.0281 (8) 0.0390 (8) −0.0023 (6) −0.0063 (6) −0.0020 (6)
C2 0.0257 (7) 0.0241 (7) 0.0332 (7) −0.0038 (5) 0.0042 (6) −0.0018 (6)
C3 0.0324 (8) 0.0204 (7) 0.0373 (8) 0.0039 (6) −0.0050 (6) −0.0041 (6)
C4 0.0342 (8) 0.0202 (7) 0.0406 (8) 0.0031 (6) −0.0035 (6) −0.0040 (6)
C5 0.0341 (8) 0.0224 (7) 0.0396 (8) −0.0002 (6) −0.0089 (6) −0.0014 (6)
C6 0.0325 (8) 0.0264 (7) 0.0455 (9) 0.0053 (6) −0.0054 (7) −0.0121 (6)
C7 0.0241 (7) 0.0237 (7) 0.0300 (7) −0.0013 (5) 0.0030 (5) −0.0008 (6)
C8 0.0314 (7) 0.0259 (7) 0.0249 (7) −0.0041 (6) −0.0037 (6) −0.0013 (5)
C9 0.0523 (10) 0.0268 (8) 0.0367 (8) −0.0006 (7) −0.0048 (7) −0.0049 (6)
C10 0.0346 (8) 0.0390 (8) 0.0325 (8) −0.0078 (7) −0.0006 (6) 0.0005 (6)
C11 0.0398 (8) 0.0354 (8) 0.0302 (8) −0.0032 (7) 0.0025 (6) 0.0019 (6)
Geometric parameters (Å, °)
O1—C2 1.2303 (17) C4—H41 0.9900
O2—C7 1.2099 (16) C4—H42 0.9900
O3—C7 1.3422 (17) C5—H51 0.9900
O3—C8 1.4722 (16) C5—H52 0.9900
N1—N2 1.1189 (18) C6—H61 0.9900
N2—C1 1.3099 (19) C6—H62 0.9900
N3—C2 1.3515 (18) C8—C10 1.506 (2)
N3—C4 1.4600 (18) C8—C11 1.511 (2)
N3—C3 1.4635 (18) C8—C9 1.513 (2)
N4—C7 1.3483 (18) C9—H91 0.9800
N4—C5 1.4490 (18) C9—H92 0.9800
N4—C6 1.4494 (19) C9—H93 0.9800
C1—C2 1.450 (2) C10—H101 0.9800
C1—H1 0.946 (17) C10—H102 0.9800
C3—C5 1.503 (2) C10—H103 0.9800
C3—H31 0.9900 C11—H111 0.9800
C3—H32 0.9900 C11—H112 0.9800
C4—C6 1.506 (2) C11—H113 0.9800
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C7—O3—C8 120.57 (10) N4—C6—H61 109.6
N1—N2—C1 179.04 (18) C4—C6—H61 109.6
C2—N3—C4 119.35 (12) N4—C6—H62 109.6
C2—N3—C3 124.53 (11) C4—C6—H62 109.6
C4—N3—C3 113.83 (11) H61—C6—H62 108.1
C7—N4—C5 125.93 (12) O2—C7—O3 125.31 (12)
C7—N4—C6 120.26 (11) O2—C7—N4 124.15 (13)
C5—N4—C6 113.59 (12) O3—C7—N4 110.52 (11)
N2—C1—C2 114.68 (13) O3—C8—C10 110.59 (12)
N2—C1—H1 115.7 (9) O3—C8—C11 109.89 (11)
C2—C1—H1 129.6 (9) C10—C8—C11 112.67 (12)
O1—C2—N3 122.08 (12) O3—C8—C9 101.68 (11)
O1—C2—C1 120.21 (13) C10—C8—C9 111.04 (12)
N3—C2—C1 117.64 (12) C11—C8—C9 110.43 (13)
N3—C3—C5 110.49 (12) C8—C9—H91 109.5
N3—C3—H31 109.6 C8—C9—H92 109.5
C5—C3—H31 109.6 H91—C9—H92 109.5
N3—C3—H32 109.6 C8—C9—H93 109.5
C5—C3—H32 109.6 H91—C9—H93 109.5
H31—C3—H32 108.1 H92—C9—H93 109.5
N3—C4—C6 110.29 (12) C8—C10—H101 109.5
N3—C4—H41 109.6 C8—C10—H102 109.5
C6—C4—H41 109.6 H101—C10—H102 109.5
N3—C4—H42 109.6 C8—C10—H103 109.5
C6—C4—H42 109.6 H101—C10—H103 109.5
H41—C4—H42 108.1 H102—C10—H103 109.5
N4—C5—C3 109.92 (12) C8—C11—H111 109.5
N4—C5—H51 109.7 C8—C11—H112 109.5
C3—C5—H51 109.7 H111—C11—H112 109.5
N4—C5—H52 109.7 C8—C11—H113 109.5
C3—C5—H52 109.7 H111—C11—H113 109.5
H51—C5—H52 108.2 H112—C11—H113 109.5
N4—C6—C4 110.27 (12)
C4—N3—C2—O1 −4.1 (2) C7—N4—C6—C4 128.14 (15)
C3—N3—C2—O1 −165.84 (14) C5—N4—C6—C4 −57.04 (17)
C4—N3—C2—C1 178.83 (13) N3—C4—C6—N4 53.39 (17)
C3—N3—C2—C1 17.1 (2) C8—O3—C7—O2 2.4 (2)
N2—C1—C2—O1 −3.6 (2) C8—O3—C7—N4 −178.51 (11)
N2—C1—C2—N3 173.55 (13) C5—N4—C7—O2 −177.86 (14)
C2—N3—C3—C5 −143.07 (14) C6—N4—C7—O2 −3.7 (2)
C4—N3—C3—C5 54.32 (16) C5—N4—C7—O3 3.0 (2)
C2—N3—C4—C6 142.52 (13) C6—N4—C7—O3 177.17 (13)
C3—N3—C4—C6 −53.89 (17) C7—O3—C8—C10 62.39 (16)
C7—N4—C5—C3 −128.35 (15) C7—O3—C8—C11 −62.62 (16)
C6—N4—C5—C3 57.18 (17) C7—O3—C8—C9 −179.61 (12)
N3—C3—C5—N4 −53.86 (17)
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Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
C1—H1···O1i 0.946 (17) 2.313 (18) 3.250 (3) 170.6 (14)
C3—H32···O1i 0.99 2.36 3.327 (3) 164
Symmetry codes: (i) −x, y+1/2, −z+1/2.
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Fig. 1
